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The golgin family of proteins plays an essential role in maintaining the structure 
and function of the Golgi apparatus. Golgin-160 is a unique golgin that promotes the 
trafficking of a specific subset of cargo proteins through a currently unknown 
mechanism. This thesis characterizes the role of golgin-160 in the trafficking of one of its 
cargo proteins, the beta-1 adrenergic receptor (1AR), and begins to connect golgin-
160’s dynamic localization with its function.  
Previous work demonstrated that golgin-160 is required for efficient delivery of 
β1AR to the plasma membrane through affecting a trans- or post-Golgi trafficking step. 
Here, we demonstrate that three basic residues in the third intracellular loop of β1AR, 
K308RR310, are critical for β1AR binding to the golgin-160 head domain, and mutation of 
these residues affects β1AR trafficking similar to golgin-160 depletion. This 1AR mutant 
can thus be used to distinguish between golgin-160 dependent and independent 
trafficking pathways. Golgin-160 affects the late Golgi trafficking of 1AR, yet it localizes 
to the cis-Golgi. Interestingly, golgin-160 disperses from Golgi membranes immediately 
after 1AR reaches the trans-Golgi. Despite not being localized with β1AR on vesicles, 
golgin-160 depletion altered the directionality and processivity, but not speed, of β1AR-
containing vesicles. This dispersal of golgin-160 from Golgi membranes prior to the 
alteration of vesicle dynamics suggests that additional proteins may be involved in 
golgin-160-facilitated trafficking of β1AR. At the trans-Golgi, β1AR selectively colocalizes 
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with golgin-97, but depletion of golgin-97 affects β1AR retrograde recycling, not 
anterograde trafficking to the plasma membrane.  
Cargo protein synchronization is a useful tool for studying protein trafficking, 
however the standard technique of using cold temperature blocks (20oC and 16oC) 
causes golgin-160 to become cytoplasmic. This dispersal correlates with a loss of active 
ADP-ribosylation factor 1 (ARF1), a small monomeric GTPase, apparently due to 
inhibition of its specific guanine nucleotide exchange factor. ARF1 activity and golgin-
160 localization slowly recovers upon return to 37oC, but these results urge caution 
when interpreting experiments that use temperature blocks. Thus, golgin-160 is 
dynamically localized at the Golgi, and this may impact its role in facilitating specific 
cargo trafficking.  
 
 
Dr. Carolyn Machamer, Advisor 
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The Golgi Apparatus 
The secretory pathway consists of three major components: the endoplasmic 
reticulum (ER) where proteins are synthesized, the Golgi apparatus where proteins are 
modified, and the endosomal system through which proteins can be trafficked or 
recycled. A recent proteomics study of human tissue estimated that 39% of human 
proteins pass through the secretory system (Uhlen et al., 2015). These proteins include 
plasma membrane proteins, secreted proteins, lysosomal proteins, and proteins 
localizing to organelles within the pathway. The Golgi apparatus is an organelle found in 
all eukaryotic species and serves a critical role within this pathway, as it is at the hub of 
anterograde and retrograde trafficking. While the Golgi has been implicated in 
functioning as a cellular sensor for multiple other processes including mitosis, apoptosis, 
and cell migration (reviewed in Glick, 2000; Wilson et al., 2011; Gosavi and Gleeson, 
2017), this dissertation focuses on its role in facilitating the modification, processing, 
and packaging of newly synthesized cargo proteins as they move through the organelle.  
This protein modification and packaging function is facilitated by the structure of 
the Golgi, though that structure itself varies among organisms (Mironov et al., 2017). 
The mammalian Golgi consists of 3 to 8 flattened membrane-bound sacks called 
cisternae that are stacked together. These stacked cisternae are divided into separate 
regions, the cis-, medial, and trans-Golgi (Nakamura et al., 2012). These regions are 
functionally distinct, for example the enzymes required at early stages of glycosylation 
concentrated on the cis face of the Golgi, and enzymes needed for the final steps 
concentrated at the trans face. In addition to ensuring that proteins are modified in an 
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accurate, sequential order, this allows for optimization of pH, ions, and substrate 
availability at each step (Stanley, 2011; Day et al., 2013; Zhang and Wang, 2016a). In 
higher eukaryotes, individual Golgi cisternae stacks are laterally joined into a ribbon-like 
structure. Interestingly, this structure is not generally required for anterograde or 
retrograde trafficking, however it may be an important signaling mechanism for the 
Golgi’s role as a cellular sensor, as mentioned above (Gosavi and Gleeson, 2017). 
How proteins move through cisternae in mammalian cells is highly debated. In 
one model, the vesicular transport model, each cisterna is static, containing specific 
enzymes needed to modify cargo (for example, enzymes required for protein 
glycosylation), and cargo is transferred between cisternae in vesicles. The opposing 
model, called the cisternal maturation model, proposes that the cargo proteins remain 
static within one cisternae while the modifying enzymes are dynamically recruited and 
removed from that cisternae (Glick, 2000). Intermediate models like the cisternal 
progenitor model, where a static cisternae produces maturing cisternae, and the rim 
progression model, in which portions of the cisternae remain static while the lateral 
edges (rims) of the Golgi progress to the next cisternae, have also been proposed, 
though as of yet no consensus has been reached (Pfeffer, 2010; Lavieu et al., 2013). 
Trafficking Through the Secretory Pathway 
The secretory pathway begins with the cotranslational insertion of proteins into 
the endoplasmic reticulum (ER). Within the ER, protein folding and modifications 
including disulfide bond formation can occur (Stanley, 2011; Spang, 2013). For proteins 
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acquiring N-glycosylation or glycophosphatidylinositol (GPI) anchors, the initial sugar 
addition also occurs in the ER. De novo ceramide synthesis also occurs in the ER, which 
then can be metabolized into other sphingolipids at the Golgi (Stanley, 2011). Newly 
synthesized proteins are then transported to the ER-Golgi Intermediate Compartment 
(ERGIC), and ERGIC-derived vesicles move on microtubules to become incorporated with 
the cis-Golgi. This fusion step, and indeed most fusion steps throughout the secretory 
pathway, requires tethering complexes (often golgins, discussed below) to interact with 
small GTPases, guanine nucleotide exchange factors (GEFs) and GTPase activating 
proteins (GAPs) to regulate that GTPase activity, and soluble N-ethylmaleimide-sensitive 
factor attachment protein receptors (SNAREs) to promote the actual fusion step 
(Bonifacino and Glick, 2004; Witkos and Lowe, 2017).   
ER resident proteins and membrane bound transport machinery from COPII 
coated vesicles are captured by machinery at the cis-Golgi and returned back to the ER, 
a step which is critical for maintaining the distinct ER and Golgi structures and functions. 
These temporarily mislocalized ER proteins often have KDEL (named after the lysine-
aspartic acid-glutamic acid-leucine) sequences or dibasic motifs which mark the ER 
proteins for retrograde transport. These proteins are incorporated into COPI coated 
vesicles through the recruitment of COPI cargo adaptors by the small GTPase ADP-
ribosylation factor 1 (ARF1; discussed in depth below) (Dong et al., 2010; Jackson, 2014). 
The Golgi-based glycosylation of proteins begins in the cis-Golgi and continues in 
the medial-Golgi (Stanley, 2011; Day et al., 2013). In these locations, different sets of 
glycosyltransferases and glycosidases, including but not limited to GlcNac-T I (mannosyl 
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(alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase) and α-mannosidase 
II, further process glycosylated proteins by adding or removing sugar groups (Stanley, 
2011).  The final sialylation of glycosylated proteins occurs in the trans-Golgi (Opat et al., 
2001; Stanley, 2011; Day et al., 2013). Furin, an endoprotease, also localizes to the 
trans-Golgi where it cleaves furin-dependent cargo (Molloy et al., 1994).  
Once all Golgi-based modifications are complete, cargo proteins must be 
accurately delivered to their proper localization, be it the plasma membrane (apical, 
basal, or nonpolarized), endosomes (late or recycling), or the extracellular space. The 
sorting and packaging step occurs at the trans-Golgi network (TGN). Recent studies have 
expanded our knowledge of different exit pathways and highlighted their complexity 
(Bonifacino and Lippincott-Schwartz, 2003; De Matteis and Luini, 2008; Anitei and 
Hoflack, 2011). This complexity begins with the sorting of cargo proteins. Cargo adaptor 
proteins recognize and bind to various cytosolic signals on membrane proteins 
(Rodriguez-Boulan and Müsch, 2005).  
One set of proteins, the cation-dependent and cation-independent mannose 6 
phosphate receptors (CD-M6PRs and CI-M6PRs), link cargo proteins and cargo adaptors. 
Acid hydrolases destined for lysosomes contain mannose 6-phosphate-recognition 
sequences that serve as signals for M6PRs binding; following that binding, the M6PRs 
recruit and bind the Golgi-localized γ-ear containing, ADP-ribosylation factor binding 
(GGA) and adaptor protein 1 (AP-1) cargo adaptor proteins at the TGN, allowing the acid 
hydrolases to be incorporated into clathrin coated vesicles (CCVs, discussed further 
below). While the GGAs bind a DXXLL motif, there are multiple AP-1 binding sites on the 
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M6PR cytoplasmic tails. The GGAs can bind directly to AP-1 so it is unknown why M6PRs 
should bind to both proteins separately. It has been hypothesized that the GGAs may 
bind earlier in the Golgi and help to direct M6PRs to AP-1 and CCVs (Ghosh et al., 2003). 
In addition to targeting sequence motifs , protein modifications such as 
glycosylation or the addition of glycosoaminoglycans (GAGs) can alter protein trafficking 
routes from the Golgi (Anitei and Hoflack, 2011; Mihov and Spiess, 2015). Lipids are 
sorted for delivery to distinct membranes, as well, and this sorting can impact protein 
cargo sorting. This can be through lipid-influenced recruitment of proteins. For example, 
PI4KIIIα (type III phosphatidylinositol 4-kinase alpha) and PI4P (Phosphatidylinositol 4-
phosphate) modulate recruitment of GBF1 (Golgi Brefeldin A Resistant Guanine 
Nucleotide Exchange Factor 1) to membranes. Lipids can also affect protein sorting 
through  phase separation of proteins due to protein interactions with their lipid 
environments (Choudhury et al., 2005; Surma et al., 2012).  
Sorting allows cargo to be incorporated into the correct type of vesicles. CCVs, 
which can form at both the TGN and the plasma membrane, were the first coated 
vesicle characterized (Bonifacino and Lippincott-Schwartz, 2003). During their 
formation, cargo from the TGN is recruited by the AP-1 and GGA cargo adaptors, while 
AP-2 is utilized at the plasma membrane (Bonifacino and Lippincott-Schwartz, 2003). AP-
1 and the GGAs are ARF1 effector proteins (discussed further below); in contrast AP-2 is 
recruited by PI(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) (Stamnes and Rothman, 
1993; Dittié et al., 1996; Jost et al., 1998). AP-1 and the GGAs are stabilized on 
membranes through binding to cargo proteins (Hirst et al., 2007; Lee et al., 2008). 
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Additionally, AP-1 binding to cargo results in a conformational change in AP-1 that 
promotes subsequent cargo binding, leading to efficient incorporation of cargo into 
forming vesicles (Lee et al., 2008). These adaptor proteins allow for clathrin triskelions 
(consisting of three light and three heavy chains) to then be recruited to Golgi 
membranes, where the complex forms a cage structure around the nascent vesicles 
(Bonifacino and Lippincott-Schwartz, 2003).  
Clathrin-independent vesicles have also been observed and characterized. The 
adaptor proteins AP-3 and AP-4 were identified by homology with AP-1 and -2 and were 
found to localize on endosomes and the TGN. Like AP-1, both AP-3 and AP-4 are ARF1 
effectors (Bonifacino and Lippincott-Schwartz, 2003; Robinson, 2004). AP-3 is one of the 
adaptors involved in cargo trafficking to lysosomes via endosomes. AP-3 can interact 
with clathrin, though clathrin is not required for AP-3 regulated cargo trafficking. AP-4 
containing vesicles, which have never been associated with clathrin, are targeted to the 
basolateral plasma membrane in polarized cells, and have been reported to deliver 
proteins to the endosome in nonpolarized cells (Anitei and Hoflack, 2011).  
In addition to small cargo transporting vesicles, large pleiomorphic structures 
have also been observed to carry cargo between organelles. These structures move 
along microtubules and some have classic coat proteins, therefore it is unclear if these 
large structures represent merged vesicles or if they formed directly from the TGN 
(Bonifacino and Lippincott-Schwartz, 2003). For the latter idea, it has been proposed 
that membrane or adaptor interactions with microtubule motor complexes pulls cargo-
filled tubules towards their destination, and vesicle fission machinery is stimulated once 
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a certain membrane tension (and not a specific vesicle size) has been reached (De 
Matteis and Luini, 2008). 
The Golgins 
In higher eukaryotes, the function of the Golgi relies on the separation of protein 
modification processes in stacked cisternae, and the ability of cargo-containing vesicles 
to accurately carry cargo to the next destination. These two activities are facilitated by a 
unique family of proteins called the golgins. First identified using antibodies found in the 
sera of patients with autoimmune diseases, the golgins have been classified by two 
features: their Golgi localization and extended α-helical coiled-coil domains. While some 
golgins are found across eukaryotes, others have specialized functions only in higher 
eukaryotes. The golgins support Golgi structure and facilitate bulk cargo trafficking 
through multiple mechanisms, particularly through promoting cisternal stacking and 
acting as tethers (Figure 1-1 and Table 1-1). 
Most golgins are cytoplasmic proteins peripherally attached to Golgi 
membranes, and many are recruited into Golgi membranes through interactions with 
small GTPases (current known interactions summarized in Table 1-1). Several golgins can 
bind to multiple GTPases, which may allow for more precise localization by requiring 
multiple GTPases to be present at the same membrane before golgins can be recruited. 
Alternatively, interactions with multiple GTPases may have functions outside of 
promoting golgin localization (Barinaga-Rementeria Ramirez and Lowe, 2009). For 
example, the GRIP (golgin-97, RanBP2α, Imh1p, and p230/golgin-245) domain 




Figure 1-1: Golgi structure, vesicles, and golgin tethers.  Schematic of stacked Golgi 
cisternae and representative golgins (discussed in depth below) facilitating anterograde 
ER-to-Golgi (p115 and GM130), retrograde intra-Golgi (giantin), and retrograde 
endosome-to-Golgi (GCC2 and GMAP210) transport. Vesicles range between 50-100 nm 
in diameter; golgins have known or predicted lengths of 50-300 nm (Truebestein and 









Table 1-1: Golgin localization, interactions with GTPases, and proposed functions at 
the Golgi. Listed below are the kingdom or subphylum in which each golgin has been 
reported, the Golgi subcompartment to which each golgin is localized and (in 
parenthesis) the protein responsible for recruiting it to that subcompartment, known 
GTPase interactors, and general roles at the Golgi. Data adapted from (Short et al., 
2005; Sinka et al., 2008; Barinaga-Rementeria Ramirez and Lowe, 2009; Munro, 2011; 
Gillingham and Munro, 2016) and NCBI HomoloGene (Agarwala et al., 2016). TMD, 
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ARF-like (ARL) GTPase, ARL1. However, these golgins can additionally bind to multiple 
members of the Rab GTPase family (Sinka et al., 2008). The three golgins that are 
concentrated on Golgi rims (giantin, golgin-85, and CASP) contain transmembrane tail 
anchors that dictate their localization, yet giantin and golgin-85 can bind to Rabs, as 
well. Vesicles are coated with Rab GTPases, and the “Rab GTPase hopping” model 
suggests that these Rabs sequentially bind to Rab binding sites along the length of a 
golgin tether, causing the vesicle to move closer to Golgi membranes (Barinaga-
Rementeria Ramirez and Lowe, 2009). 
Two non-golgin proteins, the cis-Golgi localized Golgi Reassembly Stacking 
Protein (GRASP) 65 and medial-Golgi localized GRASP55, were initially thought to staple 
mammalian Golgi cisternae together. Further research suggested that, while they may 
have redundant roles, the two GRASPs actually form homo-oligomers in trans across 
cisternae (Bachert and Linstedt, 2010). The conformation required for this interaction is 
dependent on GRASP interactions with golgins – GM130 binds to GRASP65, and 
GRASP55 recruits golgin-45. Recent crystal structures have helped to elucidate how 
these golgins interact with the GRASP proteins to facilitate cisternae stacking and, in the 
case of GRASP65 and GM130, vesicle tethering (Hu et al., 2015; Zhao et al., 2017). 
GRASPs may also promote the formation of the lateral connections between cisternae 
that create the Golgi ribbon structure (Zhang and Wang, 2016b).  
Due to their extended coiled-coil domains, golgins have long been considered 
ideal candidates for tethering functions. The domain structure of GMAP210 has 
implicated it in tethering vesicles to the Golgi: its C-terminal GRIP-related ARF-binding 
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(GRAB) domain binds Arf1 (this binding results in GMAP210 recruitment to the cis-Golgi) 
and the N-terminus of GMAP210 has an amphipathic lipid-packing sensor (ALPS) motif 
that binds to curved membranes (i.e. vesicles). One hypothesis of golgin function is 
based on this idea of Golgi-golgin-vesicle interaction. It proposes that golgins extend out 
from Golgi membranes, surrounding the organelle like “tentacles,” and that vesicles (or 
other membranes) that enter this matrix will be blocked from interacting with the Golgi 
until the appropriate golgin on the appropriate cisternae recognizes its vesicle-localized 
binding partners (Munro, 2011). This theory is supported by the finding that golgins 
ectopically anchored to mitochondrial membranes can redirect certain subtypes of 
vesicle away from the Golgi to mitochondria. Golgins localized at the cis-Golgi recruit ER-
derived vesicles, and trans-Golgi golgins recruit retrograde endosome-to-Golgi vesicles 
(Wong and Munro, 2014). This specificity is determined by short sequence motifs within 
the golgin N-termini (Wong et al., 2017). 
How this golgin tethering function promotes vesicle fusion is not clear, and may 
depend on the golgin involved. Many golgins have breaks in their coiled-coil domains, 
leading to the hypothesis that golgins can bend at these unstructured regions, bringing 
tethered vesicles closer to Golgi membranes. This was demonstrated to be the case for 
the trans-Golgi localized GCC2 (also called GCC185). Atomic force microscopy 
demonstrated that GCC2 dimers have a loose bubble-like hinge in the middle of the 
coiled-coil that can bend, bringing the cargo-binding GCC2 N-terminus close to the 
Golgi-binding C-terminus (Cheung et al., 2015). Golgins can, in some cases, promote 
vesicle fusion through the interaction with SNARE proteins. The best-studied example is 
14 
 
the interaction between GM130, p115, and SNAREs. GM130 is localized to the Golgi by 
GRASP65, and p115 can bind to the N-terminus of GM130. The p115 protein can also 
bind to COPII coated vesicles derived from the ER (see Figure 1-1). The interactions 
between these proteins alter vesicle fusion through modulating SNARE complex 
formation. GM130 binding to syntaxin 5, a member of the SNARE complex at the cis-
Golgi, blocks fusion by preventing syntaxin 5 from interacting with other SNARE 
complexes. In contrast, p115 binding promotes SNARE complex formation. GM130 
binding to p115 inhibits GM130 function, allowing for SNAREs to form a complex and for 
vesicle fusion to occur (Barinaga-Rementeria Ramirez and Lowe, 2009). 
The first vesicle tethering structures to be described were oligomeric tethers 
that can interact with both SNAREs and small GTPases. The Golgi-localized complexes, 
including the Transport Protein Particle (TRAPP), Conserved Oligomeric Golgi (COG), and 
Golgi-associated Retrograde Protein (GARP) complexes, are smaller than golgins and 
recently it has been proposed that golgins are responsible for initially tethering vesicles 
to Golgi membranes, but then vesicles are passed to the oligomeric tethering 
complexes, which can promote the actual fusion step (Witkos and Lowe, 2017). 
The membrane and vesicle tethering mechanisms described above promote bulk 
(cargo nonspecific) trafficking through the Golgi. Possibly due to these general or wide-
encompassing roles, it has been thought that golgins have semi-redundant functions. 
Indeed, most experiments involving depletion or knock out of single golgins have only 
mild effects on protein trafficking (Munro, 2011; Wong and Munro, 2014). However, 
three golgins have been shown to promote the trafficking of specific cargo proteins. E-
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cadherin was shown to colocalize with golgin-97, but not other GRIP-domain containing 
golgins, in TGN-derived tubules and depletion of golgin-97 caused intracellular 
accumulation of E-cadherin (Lock et al., 2005). Depletion of another GRIP domain golgin, 
p230 (also known as golgin-245), had no effect on E-cadherin surface delivery, but p230 
was required for tumor necrosis factor-α (TNF) delivery to the plasma membrane (Lieu 
et al., 2008).  Golgin-160, the most studied golgin, is described in depth below.  
Golgin-160 
Similar to other golgins, golgin-160 was discovered as an autoantigen in immune 
compromised patients (Fritzler et al., 1993). It is the product of the GOLGA3 gene, found 
only in vertebrates, and the predominant splice isoform is 1498 amino acids long. It 
contains the typical golgin extended alpha helices in the C-terminal two thirds of the 
protein (residues 394-1400; Misumi et al., 1997) through which it can form coiled-coil 
homodimers (Hicks and Machamer, 2002). Golgin-160 is a peripheral protein. The 
predicted globular head domain of Golgin-160 (residues 1-393) contains Golgi targeting 
information between residues 172-257. Interestingly, the N-terminus also contains a 
cryptic nuclear localization signal (P232REKKTSK239) that redirects truncations of the head 
domain to the nucleus, but is apparently inactive in the full-length protein (Hicks and 
Machamer, 2002). Figure 1-2 depicts the general structure of a golgin-160 monomer, as 
well as regions involved in golgin-160 localization and binding to interacting proteins. 
Despite structural similarities to other golgins, golgin-160 has several unique 
functions that separate it from other members of the golgin protein family. Golgin-160 





Figure 1-2: Golgin-160 structure and features. Schematic of golgin-160 structure. The N-
terminal head domain (residues 1-393) is predicted to form a globular structure and is 
expanded here to show the overlapping Golgi targeting region, cryptic nuclear 
localization signal (NLS), and β1AR binding regions. Arrowheads indicate caspase 
cleavage sites. The C-terminus consists of elongated regions of alpha-helical coiled coil 






bind to the head domain of golgin-160, while the inactive ARF1 T31N does not. Golgin-
160 recruitment to the Golgi is also dependent on the ARF1 GEF, GBF1 (Yadav et al., 
2012). While ARF1 has reported functions at both the cis- and trans-Golgi (Orci et al., 
1993; Stamnes and Rothman, 1993), golgin-160 is concentrated on the cis face of the 
Golgi (Hicks et al., 2006). Golgin-160 has no reported role as a tether, rather it has 
several functions including: maintaining Golgi position and cell polarization, responding 
to secretory stresses, and in promoting the trafficking of specific cargo proteins (Mancini 
et al., 2000; Maag et al., 2005; Bundis et al., 2006; Hicks et al., 2006; Williams et al., 
2006; Yadav et al., 2009, 2012).  
When cells migrate towards cues (for example, during wound healing or towards 
a chemoattractant) the Golgi repositions to face the wounded edge (Kupfer et al., 1982). 
Yadav et al. (2009) reported that golgin-160 is required for this Golgi repositioning 
during wound healing, and loss of golgin-160 led to impaired cell polarization. It was 
proposed that the role of golgin-160 in positioning the Golgi apparatus was due to its 
interaction with the motor protein dynein (Yadav et al., 2012). 
Another proposed role for golgin-160 is in responding to cell stresses at the early 
stages of apoptosis. Golgin-160 can be cleaved in vitro by caspases-2, -3, and -7. In cell 
culture, golgin-160 is initially cleaved by caspase-2 before undergoing further cleavage 
after cells are treated with staurosporine (Mancini et al., 2000). Golgin-160 is cleaved at 
an early stage in apoptosis triggered by ER stress or ligation of death receptors. Stable 
expression of non-cleavable golgin-160 leads to a decrease in apoptosis induced by 
these apoptotic signals, indicating that golgin-160 cleavage may integrate apoptotic 
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signals with specific cellular stress responses. This integration is likely to be upstream of 
caspase activation, as expression of a caspase-resistant golgin-160 inhibited conversion 
of pro-caspase-2 and -8 into their cleaved, active forms (Maag et al., 2005). The N-
terminus of golgin-160 is also phosphorylated (Misumi et al., 1997) by mixed lineage 
kinase 3 (MLK3), and overexpressing MLK3 led to an increase in caspase-3 cleavage of 
golgin-160, indicating that phosphorylation of golgin-160 may impact golgin-160 
cleavage (Cha et al., 2004). 
This dissertation explores the role of golgin-160 in facilitating the trafficking of 
specific cargo proteins. It was initially reported that golgin-160 binds directly to PIST 
(post-synaptic density (PDZ) domain protein interacting specifically with TC10; also 
known as CAL, GOPC, and FIG) in an isoform-specific manner (Hicks and Machamer, 
2005). PIST has been implicated in trafficking a subset of membrane proteins, and its 
interaction with golgin-160 indicated that golgin-160 might have a role in protein 
trafficking, as well. Indeed, further studies have demonstrated that golgin-160 interacts 
with and promotes the trafficking of three cargo proteins: the beta-1 adrenergic 
receptor (β1AR), glucose transporter type 4 (GLUT4), and renal outer medullary 
potassium channel (ROMK) (Bundis et al., 2006; Hicks et al., 2006; Williams et al., 2006). 
There are likely more golgin-160 dependent cargo proteins that are currently unknown; 
advances in proteomics show promise in identifying novel interacting proteins and cargo 
(Huttlin et al., 2015). 
β1AR is the main adrenergic receptor in human cardiomyocyte cells. β1AR is a G 
protein coupled receptor (GPCR), which binds adrenaline and noradrenaline and signals 
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to increase heart rate through the parasympathetic response and its function in 
stimulating cyclic AMP (cAMP) signaling . Both increased cell surface levels and 
depletion of β1AR from cells are associated with heart disease, and β1AR is the main 
target of beta blockers for treatment of chronic heart failure (Port and Bristow, 2001; 
Wallukat, 2002; Christensen et al., 2010; Xiang, 2011; Woo and Xiao, 2012). To ensure 
proper signaling, β1AR delivery to and retrieval from the plasma membrane must be 
tightly regulated. β1AR internalization, resensitization, and recycling back to the plasma 
membrane is linked to its phosphorylation state (Rapacciuolo et al., 2003; Gardner et 
al., 2004). β1AR recycling is also mediated by a dynamic palmitoylation site on its C-
terminal tail (Zuckerman et al., 2011). 
While β1AR can bind to the PDZ domain of PIST (He et al., 2004),it was found 
that golgin-160 can bind to β1AR directly, without PIST (Hicks et al., 2006). This binding 
occurs between the head domain of golgin-160 (within residues 140-257) and the third 
intracellular loop of β1AR. Depletion of golgin-160 led to a decrease in the steady state 
surface levels of exogenously expressed β1AR in HeLa cells, which is due to a decrease in 
the rate of arrival of β1AR at the plasma membrane. Intriguingly, examination of the 
rate of β1AR oligosaccharide maturation demonstrated that trafficking to the trans-
Golgi is identical with or without golgin-160, indicating that golgin-160 is affecting 
trafficking when β1AR is either at or past the trans-Golgi (Hicks et al., 2006). 
Overexpression of golgin-160 results in increased β1AR surface levels, suggesting that 
golgin-160 not only promotes efficient trafficking of β1AR to the plasma membrane, it is 
also a limiting factor in β1AR trafficking in HeLa cells (Hicks et al., 2006). This result is in 
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contrast to overexpression of PIST, which causes a reduction in β1AR surface levels (He 
et al., 2004). This complex regulation is particularly interesting in light of the recent 
discovery that Golgi-localized β1AR is functionally active and is responsible for ~40-50% 
of cellular cyclic AMP signaling (Irannejad et al., 2017). Golgin-160 may be important for 
maintaining a balanced pool of plasma membrane and Golgi localized β1AR. 
Golgin-160 also mediates the trafficking of the glucose transporter GLUT4. 
Predominantly found in adipocytes and muscle cells, GLUT4 is a high affinity glucose 
transporter that translocates to the plasma membrane in the presence of insulin. In the 
absence of insulin, GLUT4 is stored in GLUT4 storage vesicles (GSVs) near the cell 
periphery (reviewed in Leto and Saltiel, 2012; Govers, 2014). Golgin-160 is upregulated 
during adipogenesis in 3T3-L1 adipocytes, and depletion of golgin-160 in these cells 
leads to a 6-fold increase in the plasma membrane levels of GLUT4 in the absence of 
insulin. Incomplete glycosylation of GLUT4 in golgin-160 depleted cells indicates that 
without golgin-160, GLUT4 bypasses both the TGN and the GSVs, instead trafficking 
directly to the plasma membrane (Williams et al., 2006). 
ROMK is an ATP-sensitive inward rectifying potassium channel that localizes to 
the apical membrane in human kidneys (reviewed in Hebert, 1995). Mutations that 
disrupt ROMK activity have been associated with Bartter’s syndrome (Simon et al., 
1996). Binding between the C-terminus of ROMK and a region within the coiled-coil of 
golgin-160 was identified in a yeast two-hybrid screen, and this interaction was 
confirmed by immunoprecipitation of full length golgin-160 by the ROMK C-terminus 
from mammalian cell lysates. Co-expression of ROMK and golgin-160 in Xenopus oocytes 
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resulted in a 3.5 fold increase in plasma membrane levels of ROMK, which led to a 2-fold 
increase in ROMK generated currents (Bundis et al., 2006). 
As discussed above, many golgins promote bulk protein trafficking through the 
Golgi. Golgin-160 is atypical due to its selective promotion of protein trafficking. In HeLa 
cells depleted of golgin-160, the vesicular stomatitis virus G protein (VSV-G) has 
unaltered intra-Golgi transport and cell surface delivery (Hicks et al., 2006). Likewise, co-
expression of golgin-160 with the human cardiomyocyte potassium channel hERG 
(human ether a-go-go-related gene) did not lead to increased currents in Xenopus 
oocytes (Bundis et al., 2006). This indicates that golgin-160 has evolved a specialized 
role distinct from most other golgins, which could be regulated by caspase cleavage in 
response to secretory pathway stress (Mancini et al., 2000; Maag et al., 2005). 
While golgin-160 has not been strongly associated with diseases in humans, 
genetic disruptions in the mice homolog, Mea2, cause male sterility. Low expression of a 
truncated form of golgin-160 in a transgenic mouse was associated with loss of 
pachytene spermatocytes, and therefore loss of spermatozoa (Matsukuma et al., 1999; 
Banu et al., 2002). A point mutation in the GOLGA3/MEA2 gene that creates a 
premature stop codon decreases golgin-160 mRNA and results in undetectable golgin-
160 protein in mice. While female mice with this mutation could produce offspring, 
male mice were sterile due to apoptosis of spermatocytes (Bentson et al., 2013). 
The lack of phenotypes outside of the testes in these golgin-160 disrupted mice 
is interesting, given the reported role of golgin-160 in facilitating the trafficking of β1AR, 
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GLUT4, and ROMK (Bundis et al., 2006; Hicks et al., 2006; Williams et al., 2006) – all of 
which cause diseases when not expressed at the proper level (Simon et al., 1996; Woo 
and Xiao, 2012; Govers, 2014). The defects in spermatogenesis in golgin-160 deficient 
mice may be due to the high requirement for protein production and trafficking in male 
germ cells: disruption of PIST in mice also leads to male sterility through disruption in 
acrosome formation, indicating the general importance of a functional secretory system 
in these cells (Yao et al., 2002). It is also possible that stress conditions, under which the 
role of golgin-160 in apoptosis may become important, would unveil new phenotypes in 
these mouse models.  
Small Monomeric GTPases 
The Golgi is a dynamic organelle; membrane fusion and fission events allow for 
proteins to enter and exit cisternae as cargo proteins are processed through and 
transported from the Golgi. The Ras superfamily of small GTPases is critical for this 
temporal regulation of protein localization and function. They do this through their 
functions as molecular switches. These GTPases have different conformations when 
bound to GTP, GDP, and when empty. Effector proteins (proteins that bind to or are 
recruited by the small GTPases in a nucleotide dependent manner) have different 
binding affinities to each of these conformations, allowing for tight temporal regulation 
of the recruitment of specific proteins. Because of this, the nucleotide binding state of 
the GTPases must be tightly controlled. Nucleotide free Rab and ARF GTPases, which are 
members of the Ras superfamily, are in a closed, autoinhibited conformation and can 
only loosely associate with membranes. They generally require a GEF to release that 
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autoinhibition, allowing them to bind both to GTP and to membranes (Nawrotek et al., 
2016). Most small GTPases have very slow or undetectable GTPase activity, which would 
result in extended recruitment of effector proteins. This is prevented by the presence of 
GAPs, which catalyze GTPase activity (reviewed in Chavrier and Goud, 1999; Donaldson 
and Honda, 2005; Spang et al., 2010). Three groups within the Ras superfamily - the Rab, 
ARF, and Arl GTPases – play essential roles in vesicle formation and fusion and are 
discussed further below. 
Rab GTPases 
The Rab GTPases constitute a large family (over 70 human Rab GTPases have 
been identified) with functions throughout the secretory and endocytic pathways. They 
have roles in sorting cargo into vesicles, trafficking vesicles along the cytoskeleton, and 
fusing vesicles at receptor membranes. Upon synthesis, Rabs are prenylated at their C-
terminus (Chavrier and Goud, 1999; Barr, 2009; Zhen and Stenmark, 2015). An extended 
C-terminal tail allows for Rabs to extend 7-8 nm away from the membranes they are 
attached to in their GTP-bound state (Gillingham and Munro, 2007). While the 
nucleotide state of Rabs is not directly tied to their membrane association, GDP 
dissociation inhibitor (GDI) proteins, which dissociate Rabs from acceptor membranes 
and transport them back to donor membranes, specifically bind to GDP-bound Rabs (a 
simplified Rab GTPase cycle is shown in Figure 1-3A). 
Rab1 is the only Rab GTPase required for anterograde trafficking through the Golgi in 
mammalian cells. It promotes the tethering of ER-derived vesicles to the early Golgi 
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through interactions with two golgins, p115 and GM130. Other Rab GTPases are 
thought to have semi-redundant roles in both anterograde and retrograde trafficking 
through the Golgi, which have been extensively reviewed (Chavrier and Goud, 1999; 
Monetta et al., 2007; Barr, 2009; Stenmark, 2009; Hutagalung and Novick, 2011; 
Langemeyer and Barr, 2012; Zhen and Stenmark, 2015). One particularly interesting 
theory on vesicle trafficking is the “Rab GTPase hopping” hypothesis, which suggests 
multiple Rab binding sites on one golgin brings vesicles close to Golgi membranes, as 
was described previously. The interactions of various golgins with members of the Rab 
family can be found in Table 1-1. 
ARF GTPases 
The ARF family of proteins is critical for protein trafficking, particularly vesicle 
coating and uncoating (reviewed in D’Souza-Schorey and Chavrier, 2006; Donaldson and 
Jackson, 2011). There are five human members of the ARF family (ARF1, 3-6) which have 
semi-redundant roles in the secretory pathway (Volpicelli-Daley et al., 2005). They 
attach to membranes through myristoyl modifications at their N-terminus, but unlike 
Rab GTPases this N-terminus is short, meaning that the ARF proteins sit close (1-2 nm) 
to membranes in their GTP-bound state (Gillingham and Munro, 2007, see Figure 1-3). 
While they share high sequence identity, there is enough variation to separate the ARFs 
into three classes based on homology: class I (ARF1 and 3), class II (ARF4 and 5), and 






Figure 1-3: Small monomeric GTPase cycle. A) Cartoon depiction of the Rab GTPase 
cycle. The Rab (purple) in its GDP-bound form is escorted to membranes by GDI. The 
Rab then attaches to membranes through its prenylated tail with the assistance of GDF 
(GDI Dissociation Factor). A Rab GEF facilitates the transition to the GTP-bound active 
state, which leads to a conformation change that promotes effector recruitment. Rab 
GAPs promote GTP hydrolysis, and GDI can then bind to the GDP-bound Rab, remove it 
from the membrane, and transfer it elsewhere in the cell. B) A cartoon depiction of the 
ARF GTPase cycle. The ARF (green) in its GDP bound form has a myristoylated tail that is 
bound in an autoinhibited conformation. Upon close proximity to membranes, it can be 
converted into its GTP-bound form by ARF GEFs. The myristoyl modification is then 
inserted into the membrane and the adjacent amphipathic alpha helix interacts tightly 
with the membrane. Like Rab GTPases, the ARF undergoes conformational changes that 
allow for effector recruitment. Upon GAP-stimulated GTP hydrolysis, the ARF 
disassociates from the membrane, returning to the cytoplasm and regaining its 












ARF1 is concentrated on the cis face of the Golgi, but has roles at the cis- and 
trans-Golgi, as well as at the plasma membrane (Dittié et al., 1996; Pepperkok et al., 
2000; Kumari and Mayor, 2008). At the cis-Golgi, the binding of ARF1 to GTP is 
promoted by the ARF1 GEF, GBF1. GBF1 is a large ARF GEF, which is a GEF subtype 
characterized by proteins containing several additional domains outside of the catalytic 
sec7 domain. GBF1 is localized to Golgi membranes by the Rab1 isoform Rab1b 
(Monetta et al., 2007). The GBF1-stimulated conversion of ARF1-GDP to -GTP creates 
conformational changes in ARF1 that allow for its N-terminal myristoylated amphipathic 
helix to insert into Golgi membranes (Antonny et al., 1997; Liu et al., 2009). As with 
other ARF GTPases, GTP binding also changes the conformation of ARF1 within the 
switch 1, interswitch, and switch 2 regions, allowing for specific binding of effector 
proteins (Donaldson and Jackson, 2011).  
One major set of ARF1 effectors at the cis-Golgi is the COPI coat proteins needed 
for retrograde trafficking. The components of the heptameric COPI coat (α/β/β’/ε/γ/δ/ζ) 
pre-assemble into a complex in the cytoplasm, and ARF1-GTP recruits the complex onto 
Golgi membranes, where it can bind to cargo proteins either directly or through cargo 
adaptors (Donaldson et al., 1992; Hara-Kuge et al., 1994). ARF1-GTP hydrolysis is 
required for both efficient incorporation of these cargo proteins into the forming COPI 
vesicles and for the uncoating of vesicles prior to fusion with the ER. This hydrolysis is 
facilitated by three ARF GAPs (ARFGAP1, 2, and 3). It has been debated whether it is the 
actual ARF1 hydrolysis that is required for these steps, or if the ARFGAPs can serve as 
ARF1 effectors with distinct roles outside of promoting GTP hydrolysis (Lee et al., 2005; 
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Spang et al., 2010). As previously discussed, golgin-160 is another ARF1 effector at the 
cis-Golgi (Yadav et al., 2012). 
At the trans-Golgi, ARF1 promotes the formation of CCVs through the 
recruitment of cargo adaptor proteins. While GBF1 can localize to the trans-Golgi, it is 
another class of large ARF GEFs known as the brefeldin A-inhibited guanine nucleotide 
exchange proteins (BIGs) that are directly responsible for ARF1 activation in this 
subcompartment. GBF1 has been implicated in initiating an ARF GEF cascade at the 
trans-Golgi, interestingly through the activation of ARF4/5. These class II ARFs then 
recruit the BIG family of large ARF GEFs, BIG1/2, which subsequently activate ARF1/3 
(Lowery et al., 2013). ARF1 then, through recruitment of the clathrin adaptor proteins 
AP-1 and the GGAs, promotes the formation of CCVs (Dittié et al., 1996; Donaldson and 
Honda, 2005).  
ARF3 is often considered to be functionally identical to ARF1 due to high 
sequence homology, though there has been relatively little direct work to test this. ARF3 
localizes at the trans-Golgi (Manolea et al., 2010), indicating that it does not contribute 
to the ARF1 function of promoting retrograde Golgi-to-ER trafficking. It has been 
implicated in promoting CCV formation at the trans-Golgi (Volpicelli-Daley et al., 2005). 
ARF3 has unique interactions with Golgi membranes, compared to ARF1, as 
demonstrated by the loss of Golgi localization of ARF3 at 20oC, while ARF1 remains 
stably associated with Golgi membranes (Manolea et al., 2010). 
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ARF4 and ARF5 are less abundant than the other ARFs and very little is currently 
known about their function in vivo. In ARF depletion experiments, double depletion of 
ARF5 with any additional ARF was associated with a defect in recycling from endosomes 
back to the plasma membrane (Volpicelli-Daley et al., 2005), and disruptions in ARF5 
binding to the golgin, Rab6-interacting (GORAB) protein have been associated with the 
recessive connective tissue disorder, gerodermia osteodysplastica (Egerer et al., 2015). 
Double depletion of ARF4 and ARF5 also inhibited both dengue and hepatitis C virus 
infection (Kudelko et al., 2012; Farhat et al., 2016), though the mechanism of this 
inhibition is unclear. 
ARF6 localizes to the plasma membrane and endosomes (Donaldson and Honda, 
2005). It is important in endocytic trafficking through modulating the activity of lipid 
modifying enzymes. It has been implicated in the internalization of GPCRs, and 
interestingly it affects internalization irrespective of the pathway (clathrin-dependent, 
clathrin-independent, or caveolae-dependent) used by the receptor (Houndolo et al., 
2005; D’Souza-Schorey and Chavrier, 2006). Outside of the secretory system, ARF6 
activity also impacts actin dynamics, membrane and cell movement, and cytokinesis 
(D’Souza-Schorey and Chavrier, 2006; Gillingham and Munro, 2007). 
ARL GTPases 
ARL GTPases interact closely with ARF and Rab GTPases in promoting trafficking 
through the secretory pathway. They have high sequence identity to ARF GTPases but 
have several differences, for example not all ARL proteins attach to membranes through 
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an N-terminal myristoyl modification. Some have no predicted modification, while 
others have acetylation or palmitoylation sites. ARL proteins generally are less 
functionally and mechanistically conserved compared to ARF family proteins (Gillingham 
and Munro, 2007). 
ARL1 is myristoylated at its N-terminus and is recruited to the trans-Golgi. Its 
recruitment is dependent on another ARL protein, ARL3, possibly in a similar ARF GEF 
cascade as GBF1 and BIG1/2, as described above, though a GEF for ARL1 has yet to be 
identified (Munro, 2005). ARL1 has been implicated in recruiting several trafficking 
related proteins to the trans-Golgi and is the only ARL currently reported to interact 
with golgins. In particular, ARL1 is required for the membrane localization of the four 
GRIP-domain containing golgins, which have generally been associated with supporting 
retrograde endosome-to-Golgi trafficking (Munro, 2011; Gillingham and Munro, 2016), 
though golgin-97 and p230 are also implicated in promoting E cadherin and TNF 
anterograde trafficking, respectively (see Table 1-1). ARL1 is also required for the 
recruitment of the BIG1/2 ARF GEFs to the trans-Golgi, but not GBF1 (Christis and 
Munro, 2012). 
Conclusions and Thesis Objectives 
Protein trafficking through the Golgi requires a complex network of proteins that 
have tightly controlled spatial and temporal regulation. The golgin family of proteins and 
small monomeric GTPases work together to allow for this dynamic regulation. Three 
golgins have been reported to affect the trafficking of specific subsets of cargo through 
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unknown mechanisms. The objective of this dissertation is to examine the role of one of 
these atypical golgins, golgin-160, in the trafficking of its cargo β1AR. This work 
identifies a tribasic motif in the third intracellular loop of β1AR that is required for 
golgin-160 binding and characterizes the phenotypic consequences of mutating this 
binding motif. Hints on the mechanism behind golgin-160 influenced trafficking of β1AR 
have been obtained through the use of cargo trafficking synchronization techniques and 
analysis of golgin-160 localization using indirect immunofluorescence microscopy. 
Golgin-160 and -97 depletion experiments paired with live cell imaging and analysis of 
β1AR cell surface delivery provide further clues about β1AR trafficking at and beyond 
the trans-Golgi, and hint at a role for vesicle adaptor complexes and motor proteins in 
golgin-160 facilitated cargo trafficking. As alterations in β1AR surface levels, as with the 
surface levels of the other golgin-160-dependent cargo proteins, can lead to disease 
states, understanding of how golgin-160 modulates cargo trafficking could be of clinical 
importance. Finally, in the process of completing this work, a standard technique to 
synchronize protein trafficking was found to induce large disruptions in the localization 
and function of multiple Golgi resident proteins. Determining the mechanism behind 
these disruptions provides new insights into the connections between small GTPases 











Three Basic Residues of Intracellular Loop 3 of the Beta-1 Adrenergic 
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G protein-coupled receptors (GPCRs) are a large family of plasma membrane 
localized receptors with a characteristic seven transmembrane domain topology. 
Through activation of heterotrimeric G-proteins, GPCRs impact a multitude of normal 
cellular and disease processes and thus their modulation is of great interest. The 
regulation of receptor desensitization, internalization, and recycling back to the 
membrane has been extensively studied; less understood is the regulation of receptor 
biosynthesis and trafficking to the plasma membrane (reviewed in Dong et al., 2007; 
Magalhaes et al., 2012).  
GPCR progression through the endoplasmic reticulum (ER) and Golgi is mediated 
by interactions with several classes of proteins. Several of these, including many PDZ 
(PSD-95, Discs-large, and ZO-1) containing proteins, interact with the C terminus of their 
GPCR binding partners, while others show specific binding to the third intracellular loops 
(Hu et al., 2000; He et al., 2004; Dong et al., 2007; Cotecchia et al., 2012). Recently, a 
highly conserved leucine in the first intracellular loop was shown to be critical for the ER 
export of multiple GPCRs through an unknown mechanism (Duvernay et al., 2009). 
Receptor-activity-modifying proteins (RAMPs) not only promote ER exit of a subset of 
GPCRs, but can influence receptor specificity at the plasma membrane (Bouschet et al., 
2005; Dong et al., 2007). GPCRs also show different requirements for Ras-like small 
GTPases during their trafficking (Wang and Wu, 2012). In this paper we focus on the 
atypical role of golgin-160 in influencing the initial delivery of the beta-1 adrenergic 
receptor (β1AR) to the plasma membrane. 
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β1AR is the primary beta adrenergic receptor in human cardiomyocytes and is 
responsible for the catecholamine-induced regulation of heart rate in the sympathetic 
“flight or fight” response. It also has been implicated in adipogenesis and memory 
formation; however, the majority of research has concentrated on its role in the heart 
as β1AR has been widely connected with heart disease (Soloveva et al., 1997; Murchison 
et al., 2004; Woo and Xiao, 2012). Both the downregulation and overstimulation of β1AR 
have been connected to myocyte apoptosis (Bristow et al., 1993; Dash et al., 2001; Port and 
Bristow, 2001). Until relatively recently, the bulk of research on the surface expression of 
β1AR has focused on its cycle of receptor desensitization, internalization, and recycling 
to the plasma membrane. This started to shift in 2004 when He et al. demonstrated that 
β1AR can be delayed at the Golgi when the Golgi resident PDZ-containing protein PIST 
(PDZ domain protein interacting specifically with TC10) is overexpressed (He et al., 
2004), and in 2006 Hicks et al. found that golgin-160 promotes trafficking of β1AR from 
the Golgi complex to the plasma membrane (Hicks et al., 2006).  
Golgins are a large family loosely characterized by their Golgi localization and 
extended coiled coil motifs and have traditionally been associated with maintenance of 
Golgi structure and assisting bulk flow of proteins through the organelle (Munro, 2011). 
Golgin-160 is a vertebrate-specific golgin that is one of only three golgins implicated in 
trafficking of specific cargoes (Lock et al., 2005; Bundis et al., 2006; Hicks et al., 2006; 
Williams et al., 2006; Lieu et al., 2008). Hicks et al. demonstrated in vitro that the third 
intracellular loop of β1AR can interact with the N-terminal head domain of golgin-160 in 
a PIST-independent manner, and that depletion of golgin-160 from HeLa cells decreases 
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the steady state surface levels of exogenously expressed β1AR without affecting 
internalization rates. Surprisingly, given the steady state localization of golgin-160 to the 
cis-Golgi, this effect on trafficking occurs at or after the trans-Golgi network (Hicks et al., 
2006). While we initially proposed that golgin-160 might promote palmitoylation of 
β1AR, we later demonstrated that palmitoylation of β1AR was independent of golgin-
160 and instead impacts receptor internalization, leaving the mechanism by which 
golgin-160 facilitates trafficking of β1AR unknown (Zuckerman et al., 2011).  
The specific interaction between golgin-160 and β1AR, in addition to being an 
unusual role for a golgin, suggests a novel mechanism of β1AR regulation independent 
of receptor desensitization and recycling. In this report, we further dissect the 
interaction between these two proteins and demonstrate that three basic residues in 
the third intracellular loop of β1AR are critical for binding to golgin-160. We further 
show that this binding is directly responsible for the efficient delivery of exogenously 





Three Basic Residues in Intracellular Loop 3 of β1AR Are Required for Direct Binding to 
Golgin-160 
We previously showed that an in vitro transcribed and translated (IVTT) 
polypeptide consisting of the third cytoplasmic loop (L3, residues 249 to 325) of β1AR 
interacts with a region of the N-terminal head domain of purified GST-golgin-160, 
between residues 140 and 257 (Hicks et al., 2006). To demonstrate that this interaction 
is direct, and not the result of other proteins present in the reticulocyte lysate, we 
performed binding assays with purified proteins. We used the NEB Intein Mediated 
Purification with an Affinity Chitin-binding Tag (IMPACT) system to create a purified, 
untagged golgin-160 head domain (residues 1 to 393) after intein cleavage. Using this 
method, we purified a protein that was detectable by immunoblotting with an antibody 
that recognizes the N-terminus of golgin-160 (Figure 2-1A). This untagged, purified 
golgin-160(1–393) was incubated with purified GST alone or GST-β1AR L3 that had been 
pre-conjugated to glutathione-Sepharose beads. Bound golgin-160(1–393) was detected using 
Coomassie blue staining (Figure 2-1B). Golgin-160 bound β1AR L3 specifically, indicating 
a direct interaction. 
Further characterization of the golgin-160 and β1AR binding interaction required 
a more robust signal, so having demonstrated that the binding is direct we returned to 
the IVTT-generated proteins. We obtained the strongest binding readout using small 






Figure 2-1. Beta-1 adrenergic receptor (β1AR) binds directly to golgin-160(1–393). 
Representative gels for the purification of golgin-160(1–393) and its binding to β1AR 
are shown. (A) The NEB IMPACT system was used to create a purified, untagged 
golgin-160(1–393) following cleavage of the intein tag. DTT-induced cleavage caused 
enrichment of an approximately 60 kDa protein, which was specifically eluted off 
of the chitin column. This protein band could be detected using immunoblotting 
with an antibody to the N-terminus of golgin-160. Input, protein added to the 
chitin column; Cleaved, protein on the chitin column after addition of DTT but 
before elution; Eluate, protein released from the column after cleavage; *, golgin-
160(1–393); **, GST fusion proteins; (B) The purified, untagged golgin-160 head 
domain was incubated with purified GST or GST-β1AR L3 pre-bound to glutathione-
Sepharose 4B beads. The beads were washed and bound golgin-160(1–393) was 
detected by Coomassie blue staining after SDS-PAGE. Note that the samples in 














the entire L3, the N-terminal half of L3 (residues 249 to 288, L3-NT), or the C-terminal 
half of L3 (residues 288 to 325, L3-CT). [35S]-labeled golgin-160(1–393) was incubated with 
GST or the GST-L3 fusions pre-bound to glutathione-Sepharose and binding was 
detected by phosphorimaging. Golgin-160 binding was specific to L3-CT (Figure 2-2A). 
Human β1AR L3 contains three evolutionarily conserved basic residues, K308RR310. 
Through targeted mutagenesis we demonstrated that this cluster of three basic residues 
is required for interaction between β1AR and golgin-160: mutating the KRR sequence to 
three alanines (L3-CT/3A) eliminated binding in vitro (Figure 2-2A). Mutation of only two 
of these residues (RR310) to alanines did not completely eliminate binding (data not 
shown). A schematic of this direct binding site on β1AR is shown in Figure 2-2B with the 
critical KRR residues highlighted in magenta. Figure 2-2C shows a schematic of golgin-
160 with its β1AR binding region highlighted in green. 
Full Length β1AR Interacts with Golgin-160 in a KRR-Dependent Manner 
The in vitro binding was performed using small fragments of β1AR attached to large 
protein tags, so to test the relevance of these data we performed pull downs of the full 
length β1AR using lysates from transiently transfected HeLa cells. GST-golgin-160(1–393) was 
pre-conjugated to glutathione-Sepharose beads before being incubated with detergent 
lysates from cells transiently expressing full-length FLAG-tagged WT or 3A β1AR. β1AR 
bound to the golgin-160 head was detected by immunoblotting for the FLAG epitope 
(Figure 2-3A). The 3A mutant showed a 77.8% decrease in binding compared to WT 







Figure 2-2. Three basic residues in the intracellular loop 3 of β1AR are required for 
binding to golgin-160. (A) Purified GST, GST-β1AR L3, GST-β1AR L3-NT, GST-β1AR L3-CT, 
or GST-β1AR L3-CT/3A were pre-bound to glutathione-Sepharose beads and incubated 
with [35S]-labeled golgin-160(1–393). After washing the beads, bound golgin-160(1–393) was 
detected by phosphorimaging after SDS-PAGE. The input lane represents 10% of the 
starting material. The GST fusion proteins were visualized for equal loading with 
Coomassie blue staining; (B) The KRR residues are located in the third intracellular loop 
of β1AR, shown in magenta in this flattened schematic of the receptor; (C) The β1AR 
binding region between residues 140 and 257 of golgin-160 is shown in green (Hicks et 




in the interaction between these two proteins. 
How does the mutation of only three residues almost completely disrupt binding? 
Human β1AR was modeled using Phyre2 with greater than 90% confidence for 87% of 
its residues using the recently crystallized turkey homologue as a template (Warne et 
al., 2008). The predicted structure is displayed in Figure 2-3C with the KRR sequence 
highlighted in magenta. An expanded surface density model of intracellular loop 3 
shows that the three basic residues are exposed on the surface of the loop. While the 
three-dimensional structure of golgin-160 is not known, the predicted globular head 
domain may form an acidic patch that can interact with this basic stretch, or 
alternatively the KRR residues may create a conformational state favorable for 
interaction with golgin-160. 
Intra-Golgi Trafficking and Ligand-Induced Internalization of β1AR Are not affected by 
the 3A Mutation 
Previous work demonstrated that golgin-160 does not impact trafficking of newly 
synthesized β1AR earlier than the trans-Golgi Network (TGN, (Hicks et al., 2006)). 
However, recently a triple arginine motif in the third intracellular loop of the α-2B 
adrenergic receptor (α2BAR) was found to mediate ER exit by influencing receptor 
interaction with the COPII-coated vesicle coat (Dong et al., 2012). To investigate 
whether the 3A mutant affects the pre-TGN trafficking of β1AR, the O-
glycosylation status of newly synthesized β1AR was examined. O-glycosylation is 





Figure 2-3. Full length β1AR interacts with golgin-160(1–393) in a KRR-dependent 
manner. (A) HeLa cells were either not transfected (N.T.) or transiently transfected 
with constructs encoding FLAG-β1AR WT or 3A. Lysates were prepared at 18 h 
post-transfection and incubated with GST- or GST-golgin-160(1–393)-conjugated 
glutathione-Sepharose beads. Bound β1AR was detected by anti-FLAG 
immunoblotting. g160, golgin-160. The ‡ indicates nonspecific binding of the 
antibody to the GST-golgin-160 fusion protein; (B) Quantification of binding after 
normalization to input, n = 7, p = 1.9 × 10−7. Error bars represent standard 
deviation; (C) Structural model of human β1AR with an expanded region showing 
the surface filling model of intracellular loop 3. The KRR sequence is shown in 
magenta, the transmembrane regions are in blue. Structure prediction was 




denaturing gels indicates arrival of β1AR to this final Golgi compartment. A metabolic 
pulse-chase experiment was performed in cells expressing FLAG-β1AR WT or 3A. After a 
15 min pulse label with [35S]methionine and [35S]cysteine, cells were harvested 
immediately (0 min) or after the indicated times of chase in unlabeled medium and 
β1AR was immunoprecipitated from the cell lysates. The shift from an immature to a 
mature, O-glycosylated form was visualized using phosphorimaging after SDS-PAGE and 
intensity of the bands measured. Three independent experiments were performed; a 
representative gel is shown in Figure 2-4A. The percent of β1AR that had reached the 
TGN was quantified by dividing the density of the mature band by the sum of the 
mature and immature band densities for each time point (Figure 2-4B). No difference in 
the rate of arrival at the TGN was observed between the WT and 3A forms of β1AR, 
indicating that β1AR 3A moves through the Golgi at the same rate as the wild type 
protein in spite of its reduced binding to golgin-160. Therefore, unlike α2BAR, these 
three basic residues do not influence ER export. 
Regulation of β1AR surface levels by endocytosis is well documented, in part due 
to beta adrenergic receptor agonists like isoproterenol (Iso), which stimulate receptor 
internalization (Sandnes et al., 1987). After internalization, the receptor can either be 
diverted to the lysosome for degradation or recycled back to the plasma membrane. 
The third intracellular loop of β1AR contains a serine only two residues downstream 
from the KRR sequence that is critical for receptor recycling (Gardner et al., 2004); 
because of this, we examined whether the 3A mutation had any effect on receptor 





Figure 2-4. Trafficking of β1AR from the ER through the Golgi is not affected by 
the 3A mutation. (A) HeLa cells were transiently transfected with cDNAs encoding 
FLAG-β1AR WT or 3A. At 18 h post-transfection, cells were pulse-labeled for 15 min 
with [35S]methionine and [35S]cysteine, chased for 0–90 min, and lysed. β1AR was 
immunoprecipitated using anti-FLAG M2 affinity gel, separated by SDS-PAGE, and 
detected by phosphorimaging. A representative gel is shown. Passage through the 
trans-Golgi Network (TGN) was observed by a shift from an immature to a fully O-
glycosylated (mature) band; (B) The percent of mature β1AR WT and 3A over 90 
min. The percent mature was calculated for each individual time point by dividing 
the mature band density by the sum of the densities for the mature and immature 




tagged β1AR WT or 3A were fed anti-FLAG antibody with or without Iso for 30 min and 
the amount of internalized receptor was compared. Representative images are shown in 
Figure 2-5A. Internalization was quantified as the fold-increase in stimulated over 
unstimulated internalization in Figure 2-5B; no significant difference was seen between 
β1AR WT and 3A. 
Taken together, the proper intra-Golgi trafficking of the 3A mutant (Figure 2-4) 
and normal internalization of the 3A mutant (Figure 2-5) indicate that disrupting the 
interaction between golgin-160 and β1AR does not affect the pre-TGN trafficking or 
plasma membrane internalization of β1AR, substantiating our golgin-160 depletion 
studies (Hicks et al., 2006). 
Steady State Surface Levels of β1AR 3A Are Decreased Compared to β1AR WT 
Golgin-160 depletion by RNA interference causes a decrease in the steady state 
surface levels of exogenously expressed β1AR (Hicks et al., 2006), so the binding-
deficient 3A mutant was predicted to also have decreased surface levels. We first 
examined this qualitatively by differentially labeling the surface and internal pools of 
β1AR using indirect immunofluorescence microscopy (Figure 2-6A). The surface pool of 
the 3A mutant, labeled with anti-FLAG antibody in the cold prior to cell fixation and 
permeabilization, was reduced compared to WT. The internal pool, labeled using an 
anti-β1AR antibody post-fixation and permeabilization, appeared to be increased in the 





Figure 2-5. Internalization of β1AR from the plasma membrane is not affected by 
the 3A mutation. (A) Representative images of internalized β1AR WT or 3A 
following 30 min stimulation by Iso. HeLa cells expressing FLAG-tagged β1AR WT 
or 3A were serum starved for 3 h before receptor internalization was analyzed. 
Mouse anti-FLAG antibodies which recognize the exposed FLAG-tag were added to 
the serum free DMEM for 30 min, with or without the agonist Iso to induce 
internalization. Cells were then briefly acid washed to remove antibody from 
receptors still at the cell surface before they were fixed, permeabilized and labeled 
with a fluorescent secondary antibody to detect internalized antibody. The total 
internal pool of β1AR was detected using a rabbit antibody to the cytoplasmic C-
terminus. Merge: red, anti-FLAG (internalized); green, anti-β1AR (total); blue, DNA 
stained with Hoechst 33258; (B) Internalization of β1AR WT or 3A was quantified 
as the fold-change of agonist-stimulated internalization over unstimulated. The 
fluorescent signal (integrated pixel density) was measured for each cell; only cells 
expressing similar levels of total β1AR were compared. Error bars represent 














plasma membrane is that β1AR 3A has a decreased half-life relative to that of the wild 
type protein. We ruled this out using both cycloheximide chase followed by 
immunoblotting and metabolic pulse-chase label followed by immunoprecipitation and 
phosphorimaging. The half-life of β1AR was 11.4 +/− 1.6 h and the half-life of the 3A 
mutant was 11.0 +/− 1.3 h using these two techniques. As the half-lives of both proteins 
were similar, we next compared the steady state surface levels of β1AR and β1AR 3A in 
a more quantifiable manner with a radiolabeled ligand binding assay. For this 
experiment, binding of [3H]-labeled CGP-12177, a beta adrenergic receptor agonist, was 
assayed in cells expressing either β1AR WT or 3A. Surface levels were determined by 
quantifying cell-associated radioactivity after subtraction of background binding to non-
transfected cells and normalization for total expression levels by immunoblotting. The 
3A mutant bound 51% less ligand than WT, implying less than half the amount of the 3A 
receptor was present at the cell surface compared to WT (Figure 2-6B).  
To ensure that the reduction in signal was not due to changes in the ligand binding site, 
we used Fluorescence Activated Cell Sorting (FACS) analysis to measure the surface 
pools of β1AR. HeLa cells transiently expressing FLAG-tagged β1AR WT or 3A for 16 h 
were surface labeled at 4°C using anti-FLAG antibody examined using FACS analysis. The 
mean fluorescence intensities of the two populations were compared as described 
(Hicks et al., 2006). The 3A mutant had an average of 34% less receptor at the plasma 
membrane compared to WT β1AR (Figure 2-6C). The 17% difference seen in the ligand 
binding assay versus the FACS analysis may reflect a change in the ligand binding pocket 
induced by the mutation, or it may be because the ligand binding assays were 
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performed somewhat earlier post-transfection than the FACS analysis (14 h vs. 16 h). At 
14 h, exogenously expressed β1AR may not have reached a steady state equilibrium at 
the plasma membrane. Nonetheless, these experiments both indicate that the 3A 
mutant is delivered less efficiently to the plasma membrane than the wild type protein. 
Further, the reductions seen in the 3A mutant surface levels are similar to the wild type 
β1AR surface levels after golgin-160 depletion (34% and 51% compared to 40%, (Hicks et 
al., 2006)). This ability of the 3A mutant to phenocopy the effects of golgin-160 
depletion on β1AR suggests that it is the lack of binding between golgin-160 and β1AR 





Figure 2-6. Steady state surface levels of β1AR 3A are decreased compared to 
β1AR WT. (A) Representative images of surface and internal β1AR WT or 3A at 5 h 
post-transfection. Cells were labeled prior to fixation and permeabilization with 
anti-FLAG antibody to detect surface β1AR and then after fixation and 
permeabilization with anti-β1AR C-terminus antibody, allowing for differential 
labeling of the surface and internal pools. Merge: red, anti-FLAG (surface); green, 
anti-β1AR (internal); blue, DNA stained with Hoechst 33258; (B) Steady state 
surface levels of β1AR WT and 3A in transiently transfected HeLa cells were 
compared using radiolabeled ligand binding at 14 h post-transfection. After 
incubation with ligand for 3 h at 4°C, cells were washed, lysed, and cell-associated 
radioactivity was determined. The surface pool of β1AR WT or 3A was calculated 
after subtracting background binding on non-transfected cells and normalizing for 
total expression level by immunoblotting. Error bars represent standard deviation, n 
= 3, p = 4.5 × 10−6; (C) HeLa cells were co-transfected with expression plasmids 
encoding cytoplasmic GFP and either FLAG-β1AR WT or 3A. Sixteen h post-
transfection, FACS analysis was performed to assess surface expression of β1AR. 
The median fluorescence intensity for β1AR was analyzed in GFP-positive cells to 
represent the average amount of β1AR at the plasma membrane. Error bars 












Golgin-160 was the first protein described to positively impact β1AR trafficking 
from the Golgi to the plasma membrane. We previously demonstrated in vitro binding 
between these two proteins (Hicks et al., 2006), but the interaction was largely 
uncharacterized. In this report, we have shown that golgin-160 can directly bind β1AR, 
that three basic residues in the third intracellular loop of β1AR are critical for the 
interaction, and that these residues are necessary for efficient β1AR trafficking from the 
Golgi to the plasma membrane in cells. 
The third intracellular loop and C-terminus are the regions of greatest variance 
between the β1 and β2 adrenergic receptors. It is thought that the differences in protein 
interactions in these two domains account for many of the functional differences 
between the two receptors (Cotecchia et al., 2012). The majority of proteins known to 
interact with β1AR bind to its C-terminal cytoplasmic tail via their PDZ domains and are 
involved in signal transduction and recycling from the plasma membrane (Cotecchia et 
al., 2012). Previously, only endophilins SH3p4 and SH3p13 have been shown to bind to 
the third intracellular loop of β1AR. This binding depends on the Src homology SH3 
domain and mediates receptor internalization and coupling with Gs (Tang et al., 1999). 
Golgin-160 binding to the third intracellular loop may influence the interactions of these 
other proteins with β1AR. He et al. found that PSD-95 can compete for a binding site 
with PIST via their PDZ domains in order to modulate β1AR trafficking (He et al., 2004); 
golgin-160 could be occluding a binding site in intracellular loop 3 in a similar manner. 
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Golgin-160 could also affect proteins binding to the C-terminal tail of β1AR. In 2007, 
Gardner et al. found that binding of a SAP97-AKAP79 protein scaffold to the C-terminus 
of β1AR was required for protein kinase A to phosphorylate a residue in loop 3, which is 
necessary for β1AR recycling to the plasma membrane (Gardner et al., 2007). In an 
analogous fashion, golgin-160 may work cooperatively with other proteins that interact 
with the C-terminus of β1AR. At present, the influence of golgin-160 on other β1AR 
binding partners has not been studied. 
To date, golgin-160 is the only protein demonstrated to interact directly with 
β1AR to regulate its Golgi to plasma membrane trafficking. This is an atypical role for a 
golgin: most golgins maintain Golgi structure or assist in global trafficking, for example 
by acting as vesicle tethers. Only two other golgins, trans-Golgi-localized golgin-97 and 
p230/golgin-245, have been implicated in trafficking of specific cargoes. Golgin-97 
colocalizes with E-cadherin in post-Golgi transport carriers and golgin-97 depletion 
inhibits E-cadherin trafficking (Lock et al., 2005). Similarly, golgin-245 colocalizes with 
tumor necrosis factor-α (TNF) in TGN tubules and depletion of golgin-245 prevents TNF 
localization to the plasma membrane (Lieu et al., 2008). Golgin-160, in addition to its 
role in facilitating plasma membrane delivery of β1AR, can bind to the apical potassium 
channel ROMK and promote its delivery to the cell surface (Bundis et al., 2006), and it is 
required for the proper localization of GLUT4 into insulin-responsive storage 
compartments (Williams et al., 2006). 
Because golgin-160 impacts efficient trafficking of β1AR and GLUT4 is 
mislocalized in its absence, we hypothesize that golgin-160 facilitates specialized sorting 
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of cargo at the TGN. The complexity of post-Golgi sorting has become more apparent in 
recent years. In non-polarized cells, it was once believed that proteins moved from the 
TGN to the plasma membrane by a single route, but it is now apparent that there are 
many routes to the cell surface (De Matteis and Luini, 2008). In polarized cells, not only 
have distinct apical and basolateral sorting pathways been demonstrated, but proteins 
headed for the same cell surface also segregate into separate transport pathways at the 
TGN based on their mode of regulation (Fölsch et al., 2009; Mattila et al., 2012; 
Arnspang et al., 2013). Very little, however, is known about the composition of these 
various transport carriers or how this differential sorting occurs. We propose that 
golgin-160 plays a role in this sorting step, guiding cargo into vesicles so that specific 
cargo can be efficiently targeted. It is possible that golgin-160 accomplishes this directly 
by moving with cargo, or it could facilitate the interaction of its cargo with another 
protein, as proposed above. Both of these possibilities will be investigated by using the 
3A mutant as a golgin-160-independent cargo protein. Since mutating only three basic 
residues dramatically interferes with this interaction, it may be that either a charged 
stretch or a three-dimensional conformation created by these three residues is critical for 
interaction with golgin-160. Our findings bring us closer to the identification of a binding 
motif, sequence-based or structural, among golgin-160 cargoes, which will then allow 
for a directed investigation into other potential cargoes including other GPCRs. 
Neither depletion of golgin-160 nor disruption of its binding to β1AR completely 
disrupts β1AR localization—more than 50% of β1AR still makes it to the plasma 
membrane. This suggests that golgin-160 is playing a regulatory role, enhancing β1AR 
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surface expression. This method of regulation is possible as golgin-160 can itself be 
subject to regulatory control. Golgin-160 is recruited to the Golgi through binding of GTP-
bound ARF1, which is in turn rapidly cycling on and off the Golgi (Presley et al., 2002; 
Yadav et al., 2012). Its localization may also be affected by interactions with dynein 
(Yadav et al., 2012). Additionally, golgin-160 can undergo cleavage by caspase-2, -3, and 
-7 as well as phosphorylation by MLK3 (Mancini et al., 2000; Cha et al., 2004). All of 
these interactions and modifications could alter the localization or conformation of 
golgin-160, which could mediate interaction with β1AR. In the future, it will prove useful 
to study the dynamics of endogenous golgin-160 and β1AR movement in the context of 




Materials and Methods 
Cells and Transfection 
HeLa cells were maintained in DMEM (Life technologies, Grand Island, NY, USA) with 
10% Fetal Bovine Serum (Atlanta Biologicals, Flowery Branch, GA, USA) and 0.1 mg/mL 
Normocin (InvivoGen, San Diego, CA, USA) at 37 °C with 5% CO2. Cells were grown in 35 
mm dishes, 6 cm dishes, or 12-well plates depending on the experiment, and 
transfected with 3 μL X-tremeGENE9 DNA transfection reagent (Roche, Indianapolis, IN, 
USA) per 1 μg DNA. 
Expression Constructs 
Glutathione S-transferase (GST) fusion proteins of golgin-160(1–393) have been previously  
described (Hicks and Machamer, 2005). The untagged golgin-160(1–393) protein was 
constructed by polymerase chain reaction (PCR) amplifying residues 1–393 from the 
previously described pBluescript SK+ golgin-160 construct (Mancini et al., 2000) and 
inserting a stop codon after residue 393, which was then inserted into New England 
Biolab’s pTBY12 vector for purification using the IMPACT system (New England Biolabs, 
Beverly, MD, USA). Human FLAG-β1AR cDNA in pcDNA3 was provided by Randy Hall 
(Emory University, Atlanta, GA, USA). The 3A mutation, converting K308RR310 to 
A308AA310, was introduced using Quikchange mutagenesis (Stratagene, La Jolla, CA, USA). 
GST-tagged β1AR loop 3 (L3) was constructed by PCR amplification of residues 249 to 
325 of β1AR and inserting the fragment into the pGEX-2T expression plasmid (GE 
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Healthcare, Little Chalfont, Buckinghamshire, UK). GST-β1AR L3 N-terminus (NT) was 
constructed by PCR amplifying residues 249 to 288 of β1AR, and the C-terminus (CT) 
likewise by PCR amplifying residues 288 to 325, followed by insertion into the pGEX-2T 
expression plasmid. GST β1AR L3CT with the 3A mutation was created by amplifying 
residues 288 to 325 from the β1AR 3A plasmid (described above), followed by insertion 
into the pGET-2T expression plasmid. The cytosolic GFP vector pEGFP C1 was obtained 
from Clontech (Mountain View, CA, USA). 
Antibodies 
Mouse monoclonal anti-FLAG was from Sigma-Aldrich (St. Louis, MO, USA). Rabbit anti-
β1AR was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-
golgin-160 was previously described (Mancini et al., 2000). R-Phycoerythrin-conjugated 
IgG goat anti-mouse was from Jackson ImmunoResearch Laboratories Inc. (West Grove, 
PA, USA). Alexa Fluor 568 anti-mouse IgG and Alexa Fluor 488 anti-rabbit IgG were from 
Life Technologies. Horseradish peroxidase (HRP)-conjugated secondary antibodies were 
from GE Healthcare. 
In Vitro Binding 
GST-fusion proteins were grown in Escherichia coli BL21 cells (Stratagene) as previously 
described (Hicks and Machamer, 2005). GST or the GST-fusion proteins were purified 
from the soluble fraction of the cell lysates according to manufacturer instructions using 
glutathione-Sepharose 4B beads (GE Healthcare). The purified proteins (5 μg each) were 
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diluted in PBS and rebound to glutathione-Sepharose 4B beads by incubating them 
overnight at 4 °C with rotation. Untagged golgin-160(1-393) was purified using the NEB 
IMPACT system as described by the manufacturer (New England Biolabs, Beverly, MD, 
USA). To confirm the purity and identity of the resulting protein, the eluate was 
separated on NuPAGE 4%–12% Bis-Tris Gel (Invitrogen, Carlsbad, CA, USA) and was 
detected by Coomassie blue staining or immunoblotted with rabbit anti-golgin-160. 
Purified golgin-160(1–393) in the elution buffer (20 mM HEPES pH 8.5, 500 mM NaCl, 1 
mM EDTA, 50 mM DTT) was added to the conjugated GST-fusion proteins and incubated 
4–6 h at 4 °C. After washing, protein remaining attached to the glutathione-Sepharose 
beads was eluted, separated by SDS-PAGE (10% gel) and detected by Coomassie blue 
staining. 
For the binding assays using in vitro transcribed and translated golgin-160, the GST-
fusion proteins were purified and 3 μg of each was rebound to glutathione Sepharose 
beads as above. IVTT [35S]-labeled golgin-160(1–393) was prepared following the 
manufacturer’s instructions and as previously described (Promega, Madison, WI, USA, 
(Hicks et al., 2006)). Golgin-160 was then diluted in binding buffer (25 mM HEPES, 125 
mM KOAc, 5 mM EDTA, 0.5% Nonidet P-40 (NP-40), 1 mM DTT) and incubated with the 
GST-fusion proteins for 2 h at 4 °C. After washing, bound golgin-160 was eluted and 
separated by SDS-PAGE followed by phosphorimaging on a PharosFX molecular imager (Bio-




Pull Downs from Cell Lysates 
HeLa cells grown to 70% confluency were left untransfected, or transfected with 0.5 μg 
of either pcDNA/WT or 3A β1AR. After incubating for an additional 16–18 h, cells were 
lysed in a potassium acetate lysis buffer (125 mM potassium acetate, 25 mM HEPES pH 
7.1, 1 mM DTT, 1% NP-40, protease inhibitor cocktail). The soluble fraction of the lysed 
cells was incubated 2 h at 4 °C with 10 μg GST alone or GST-tagged golgin-160(1–393) that 
had been pre-conjugated to glutathione-Sepharose 4B beads. After washing the beads 
twice with lysis buffer, protein bound to the beads was separated by SDS-PAGE and 
β1AR was detected by immunoblotting with anti-FLAG antibody followed by ECL. The 
amount of protein in the input and pull down bands was measured after imaging on a 
VersaDoc Imaging System Model 5000 (Bio-Rad, Hercules, CA, USA) using Quantity One 
volume analysis tools (Bio-Rad, Hercules, CA, USA). Percent bound was calculated after 
first normalizing 3A and WT to their input and significance was calculated using a 
heteroscedastic two-tailed Student’s t-test. 
Modeling of β1AR 
The nucleotide sequence of the human β1AR mRNA was obtained from NCBI for the 
Homo sapiens adrenoceptor beta 1 (ADRB1) mRNA (Accession number NM_000684). 
The corresponding amino acid sequence was submitted for intensive modeling to the 
Protein Homology/analogY Recognition Engine (PHYRE) V 2.0 server (Structural 
Bioinformatics Group, London, UK). The resulting predicted protein structure was then 
visualized using PyMOL (Schrödinger, Portland, OR, USA). 
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Metabolic Pulse-Chase and Immunoprecipitation 
HeLa cells grown to 70% confluency were transiently transfected with 0.5 μg 
pcDNA/FLAG-β1AR WT or 3A. At 15–18 h post-transfection, cells were pulse labeled for 
15 min with [35S]methionine and [35S]cysteine. For following movement of β1AR to the 
TGN, cells were chased for 0–90 min and lysed on ice for 5 min in 1% NP-40, 0.4% 
deoxycholic acid, 50 mM Tris pH 8, 62.5 mM EDTA pH 8, with protease inhibitor cocktail 
(Sigma-Aldrich). For determination of the half-life of β1AR, cells were chased for 0, 3, 6, 
or 9 h and lysed as described above. β1AR was immunoprecipiated with anti-FLAG-M2 
affinity gel (Sigma-Aldrich, St. Louis, MO, USA), and after washing, the samples were 
eluted and separated by SDS-PAGE. The density of protein bands was measured using 
Quantity One volume analysis tools (Bio-Rad, Hercules, CA, USA) after phosphorimaging 
as described above. 
Receptor Internalization  
HeLa cells at 70% confluency on coverslips in 35 mm dishes were transfected with 0.5 μg 
of either pcDNA/FLAG-β1AR WT or 3A. After 16–18 h the medium was switched to 
serum-free DMEM for 3 h. For the internalization assay, 1 μg/mL mouse anti-FLAG 
antibody was added to the serum-free medium with or without 10 uM isoproterenol 
(Iso, Sigma-Aldrich) for 30 min at 37 °C. Cells were then washed with PBS and left 
untreated or remaining surface antibody was removed with an acid wash (0.5 M NaCl, 
0.5% HOAc, pH 1) for 1 min at room temperature. Cells were then fixed and 
permeabilized as previously described (Hicks et al., 2006) and the internal pool of β1AR 
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detected using the rabbit anti-β1AR C-terminal antibody described above. Alexa Fluor 
568 anti-mouse IgG and Alexa Fluor 488 anti-rabbit IgG were used for secondary labeling 
and Hoechst 33258 was used as a DNA stain. Cells with similar rabbit anti-β1AR signal 
intensity were selected for comparison and all images were taken on the same day with 
the same exposure on an Axioskop microscope (Zeiss, Thornwood, NY, USA) equipped 
with epifluorescence using an ORCA-03G charge-coupled device camera (Hamamatsu, 
Japan) using iVision software (BioVision Technologies, Exton, PA, USA). The integrated 
pixel density of the anti-FLAG signal for each cell was determined using Image J 
(National Institutes of Health, Bethesda, MD, USA) and was normalized to background 
fluorescence. Statistical analysis was performed using a two-tailed heteroscedastic 
Student’s t-test. 
Surface Immunofluorescence 
HeLa cells grown to 70% confluency on coverslips in 35 mm dishes were transfected 
with 0.5 μg of either pcDNA/FLAG-β1AR WT or 3A. After 5 h the cells were rinsed in ice 
cold PBS and incubated on ice with mouse anti-FLAG antibody for 15 min. Cells were 
then fixed and permeabilized as previously described (Hicks et al., 2006) and the 
internal pool of β1AR detected using the rabbit anti-β1AR C-terminal antibody described 
above. Alexa Fluor 568 anti-mouse IgG and Alexa Fluor 488 anti-rabbit IgG were used for 
secondary labeling and Hoechst 33258 was used as a DNA stain. All images were taken 
on the same day with the same exposure on an Axioskop microscope (Zeiss, Thornwood, 
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NY, USA) equipped with epifluorescence using an ORCA-03G charge-coupled device 
camera using iVision software (version 4.5.1, BioVision Technologies, Exton, PA, USA).  
Cycloheximide Chase  
HeLa cells were grown to 70% confluency in 35 mm dishes and were transfected with 
0.5 μg of either pcDNA/FLAG-β1AR WT or 3A. After 16 h the cells were rinsed in PBS and 
incubated with DMEM containing 100 μg/mL cycloheximide (Calbiochem, La Jolla, CA, 
USA). After 0, 2, 4, 6, and 8 h, cells were lysed on ice for 5 min in 1% NP-40, 0.4% 
deoxycholic acid, 50 mM Tris pH 8, 62.5 mM EDTA pH 8, with protease inhibitor cocktail. 
Soluble protein was separated by SDS-PAGE and immunoblotted with rabbit anti-β1AR 
antibody. 
Radiolabeled Ligand Binding 
HeLa cells at 70% confluency on 12-well plates were transfected with 0.12 μg 
pcDNA/β1AR WT or 3A per well in triplicate. Nontransfected cells were used to 
determine background binding. After 14 h, cells were washed in cold PBS and incubated 
with 10 nM [3H]-labeled CGP-12177 (PerkinElmer Life Sciences, Waltham, MA, USA) 
diluted in KRH buffer (136 mM NaCl, 4.7 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 20 
mM HEPES, pH 7.4, and 2 mg/mL BSA) for 3 h at 4 °C. Cells were then washed in PBS and 
lysed as described above. Cell-associated radioactivity was determined using a Beckman 
Coulter LS6500 scintillation counter (Brea, CA, USA). Total expression level was 
determined by immunoblotting lysate prepared from a parallel transfected dish with 
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anti-FLAG antibody followed by ECL. Three independent experiments (each done in 
triplicate) were averaged. Statistical analysis was performed using a two-tailed 
heteroscedastic Student’s t-test. 
FACS Analysis 
HeLa cells growing in 6 cm dishes to 70% confluency were co-transfected with 1.5 μg 
cytosolic GFP (pEGFP-C1) and 0.5 μg of either pcDNA/FLAG-β1AR WT or 3A. After 16-18 h, 
cells were harvested by trypsinization before being washed twice with DMEM and 
resuspended at (5–10) × 106 cells/mL in blocking solution (1% BSA in PBS). After blocking 
for 30 min on ice the cells were incubated 1 h on ice with monoclonal mouse anti-FLAG 
diluted in blocking solution. Cells were washed in PBS and then were incubated 1 h on 
ice in phycoerythrin-labeled goat anti-mouse IgG, also diluted in blocking solution. Cells 
were washed again in PBS before being resuspended in serum-free DMEM and analyzed 
using a FACSCalibur flow cytometer (Becton Dickinson, Franklin Lake, NJ, USA). The 
mean phycoerythrin fluorescence intensity of cells expressing GFP was calculated for 
each sample using CellQuest Pro software (Becton Dickinson). Significance was 
















Protein processing through the secretory pathway can be divided into three 
general stages: synthesis, modification, and then delivery of proteins to their final 
destination. Recent reviews have emphasized the complexity of this final step, both in 
sorting proteins into appropriate carriers for post-Golgi delivery, and in successfully 
transporting those carriers to their target membrane (Anitei and Hoflack, 2011). One 
family of proteins, the golgins, has been implicated in supporting bulk protein trafficking 
through and out of the Golgi, particularly through their roles as vesicle tethers 
(Gillingham and Munro, 2016; Witkos and Lowe, 2017). Three golgins (golgin-160, 
p230/golgin-245, and golgin-97) have been reported to have the ability to promote the 
trafficking of specific subsets of cargo proteins (Lock et al., 2005; Hicks et al., 2006; Lieu 
et al., 2008).  
Golgin-97 and p230 are both GRIP (golgin-97, RanBP2α, Imh1p, and p230/golgin-
245) domain containing golgins that localize to the trans-Golgi network (TGN) through 
interaction with ADP ribosylation factor-like GTPase 1 (ARL1; Munro, 2005). But despite 
having similar targeting mechanisms, GRIP domain containing golgins do not 
heterodimerize with each other and separate into distinct subdomains of the TGN 
(Gleeson et al., 2004). This could explain previous findings that golgin-97 colocalizes 
with and promotes the trafficking of E-cadherin, but does not influence the surface 
delivery of tumor necrosis factor α (TNF) while p230 facilitates the surface delivery of 




The third atypical golgin, golgin-160, has been implicated in the trafficking of 
three proteins: the glucose transporter type 4 (GLUT4), renal outer medullary potassium 
channel (ROMK), and beta-1 adrenergic receptor (β1AR; Bundis et al., 2006; Hicks et al., 
2006; Williams et al., 2006). Golgin-160 is localized to the cis-Golgi in an ADP-
ribosylation factor 1 (ARF1) and Golgi Brefeldin A Resistant Guanine Nucleotide 
Exchange Factor 1 (GBF1) dependent manner, yet it affects the post-Golgi trafficking of 
GLUT4 and β1AR (Hicks et al., 2006; Williams et al., 2006; Yadav et al., 2012). In cells 
depleted of golgin-160, GLUT4 bypasses the trans-Golgi and GLUT4 storage vesicles and 
is delivered directly to the plasma membrane (Williams et al., 2006). β1AR has a 
decreased rate of arrival at the plasma membrane but unaffected intra-Golgi trafficking 
in cells lacking golgin-160 (Hicks et al., 2006).  
β1AR is the main adrenergic receptor in human cardiomyocytes (Wallukat, 
2002). A G protein coupled receptor (GPCR), its localization, sensitization, and 
internalization is highly regulated by phosphorylation (Gardner et al., 2004, 2006, 2007). 
Both increased and decreased function of β1AR at the cell surface have been associated 
with heart disease, and it is the main cellular target of the commonly used beta blocker 
medications (Bristow et al., 1993; Port and Bristow, 2001; Woo and Xiao, 2012). 
Interestingly, recent reports have demonstrated that β1AR not only signals from the 
plasma membrane, but that β1AR at the Golgi can also be activated by ligands to initiate 
a signal cascade (Irannejad et al., 2017).  
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In this chapter, we investigated the mechanism behind the golgin-160 facilitated 
trafficking of β1AR. We found that β1AR trafficking through the Golgi-induces changes in 
golgin-160 localization that may be required for the function of golgin-160, and 
investigate the impact of golgin-160 depletion on post-Golgi vesicle dynamics. We also 





Golgin-160 loses its Golgi localization when β1AR is constitutively expressed 
Golgin-160 facilitates the trafficking of β1AR through a currently unknown 
mechanism (Hicks et al., 2006; Gilbert et al., 2014). As we investigated this role of 
golgin-160, we discovered that constitutive expression of β1AR in HeLa cells led to a 
25% decrease in Golgi localized golgin-160 (Figure 3-1A and C). Golgin-160 is an ARF1 
effector protein that is peripherally and dynamically associated with Golgi membranes 
(Yadav et al., 2012). At the cis-Golgi, ARF1 is activated by its GEF, GBF1. If golgin-160 was 
dispersing from Golgi membranes due to a decrease in the levels of ARF1-GTP, supplying 
an excess of GBF1 could increase the cellular pool of ARF1-GTP and prevent golgin-160 
dispersal. However, we did not observe any protective effect of co-transfecting GBF1 
and β1AR (23% decrease, Figure 3-1B and C). We therefore hypothesize that loss of 
golgin-160 localization on Golgi membranes could be required for its function in 
promoting β1AR cell surface delivery, and not merely a consequence of altering the 
ARF1 nucleotide binding state. 
Loss of golgin-160 localization occurs as β1AR reaches a golgin-97 containing TGN 
compartment 
We next wanted to understand the timing of golgin-160 dispersal in order to 
elucidate its role in β1AR trafficking. Synchronization of cargo trafficking at distinct 
compartments within the secretory pathway allows for precise control of when proteins 







Figure 3-1: Golgin-160 loses its Golgi localization when constitutive β1AR is expressed, 
and this is not rescued by GBF1 overexpression. Representative images of HeLa cells 
transfected with (A) β1AR alone or (B) β1AR and GBF1 for 18 h. Cells were labeled with 
rabbit anti-golgin-160 and mouse anti-GM130, followed by Alexa Fluor 488 anti-rabbit 
IgG and Alexa Fluor 546 anti-mouse IgG. Arrows indicate the Golgi regions of β1AR 
expressing cells. (C) Quantification of golgin-160 dispersal. The GM130 signal was used 
to outline the Golgi region in each cell, and the amount of golgin-160 fluorescent signal 
was measured within the Golgi and divided by the total golgin-160 fluorescence in the 
cell to obtain the percent of golgin-160 at the Golgi. Each fluorescence intensity value 
was normalized to nontransfected cells. Two independent experiments were 
performed, and n=39-43 cells were quantified per condition. p<0.001 for all 
comparisons of untransfected to transfected conditions, but the difference between 









technique, 20oC and 16oC cold temperature blocks, caused golgin-160 to become 
cytoplasmic (see Chapter 4), we investigated alternative means of synchronization.  
The Retention Using Selective Hooks (RUSH) system, developed by the Perez lab 
(Boncompain et al., 2012), uses the relative affinities of streptavidin, streptavidin 
binding peptide (SBP), and biotin to regulate protein trafficking. This system utilizes 
three components: a Hook protein (here, we utilized the ER-localized major 
histocompatibility complex (MHC) class II invariant chain (Ii), abbreviated MHCII below) 
that is fused with streptavidin, a cargo protein of interest (here, mCherry-tagged β1AR) 
that has a SBP tag added to its luminal N-terminus, and membrane permeable biotin. 
The Hook and β1AR are encoded on a bicistronic plasmid, and upon plasmid transfection 
and expression, the Hook streptavidin interacts with the β1AR SBP, retaining β1AR in the 
ER. Biotin can outcompete the SBP tag for streptavidin binding, causing β1AR to be 
released to traffic through the secretory system normally (schematic in Figure 3-2A). 
Transient transfection of HeLa cells with the RUSH β1AR plasmid led to an accumulation 
of β1AR in the ER in the absence of biotin (Figure 3-2B). After a 30 min treatment with 
10 μM biotin, β1AR was observed to localize to the Golgi by indirect 
immunofluorescence microscopy. Surface staining using an antibody against β1AR at 
these two conditions revealed that no β1AR was localized at the plasma membrane. 
After 1 h biotin treatment, β1AR could be observed at the plasma membrane by surface 
staining. 
Using the RUSH system, we were able to gain temporal understanding of golgin-







Figure 3-2: The RUSH system allows for a synchronized bolus of β1AR to travel through 
the Golgi. (A) Schematic of synchronized β1AR trafficking using the RUSH system. 
Interactions between and localizations of the mCherry-SBP-tagged β1AR construct 
(blue), the streptavidin MHCII ER hook (red), golgin-160 (green), and biotin (yellow) are 
drawn in the absence of biotin, and in the presence of biotin over time as β1AR travels 
through the Golgi and into post-Golgi vesicles. (B) HeLa cells transfected with RUSH 
β1AR for 20 h were treated with 10 uM biotin for 0, 30, or 60 min. Surface β1AR was 
labeled with a mouse anti-mCherry antibody on intact cells, and the total β1AR 
fluorescence was detected using a rabbit β1AR specific antibody, followed by labeling 











structure of the mammalian Golgi, colocalization can be difficult to accurately measure 
in the intact Golgi by light microscopy. To simplify this, we added 1 μg/mL nocodazole to 
HeLa cells expressing RUSH β1AR. Nocodazole disrupts the microtubule network and 
causes the Golgi to separate into ministacks. These ministacks still contain cis, medial, 
and trans cisternae, but are no longer laterally tethered to other Golgi stacks and are 
diffusely localized through the cell. β1AR can still traffic to the plasma membrane in 
nocodazole treated cells, though trafficking is slower than in untreated cells (Figure 3-
3A). β1AR reached Golgi ministacks within 20 minutes of biotin addition, where it 
colocalized with golgin-160 in cis-Golgi cisternae. At 40 minutes post biotin, β1AR 
localized to cisternae marked by the trans-Golgi protein, golgin-97. At this time, loss of 
membrane-associated golgin-160 was observed. β1AR colocalization with golgin-97 and 
the loss of golgin-160 membrane localization was still observed 60 minutes post biotin 
addition, but by 80 minutes post biotin addition β1AR was observed at the plasma 
membrane and golgin-160 was once again observed on Golgi membranes. This indicates 
that golgin-160 becomes dispersed from Golgi membranes after β1AR has passed 
through the cis-Golgi, and can return to the cis-Golgi either after a set period of time 
(between 20-40 minutes in the absence of an intact microtubule network) or after β1AR 
has left the trans-Golgi. 
RUSH synchronized β1AR traveled sequentially from golgin-160 containing 
cisternae to golgin-97 containing cisternae. Pearson’s r colocalization coefficient was 
measured for β1AR and each of the golgins, and a spike in the colocalization of β1AR 





Figure 3-3: Golgin-160 loses membrane localization as β1AR localizes with golgin-97 at 
the trans-Golgi network. (A) Golgin-160 (green) loses Golgi localization during 1AR 
(blue) trafficking 40 min after biotin addition, and recovers after 80 min biotin 
treatment when β1AR has left the Golgi and reached the PM. 1AR colocalizes with 
golgin-97 (red) 40-60 min post biotin addition. Insets of the small boxed regions depict 
the localizations of two proteins per box for clarity. Left inset: comparing golgin-160 and 
golgin-97 localization. Center inset: Comparing golgin-160 and β1AR localization.  Right 
inset: comparing β1AR and golgin-97. (B) Quantification of the Pearson’s r correlation 
coefficient between 1AR and either golgin-160 or golgin-97 over the first 60 minutes of 
trafficking. (C) 1AR does not colocalize with another trans-Golgi golgin, p230 in a 
similar assay to that performed in (A). Left inset: enhanced view of the boxed region for 
clarity. Right inset: comparing only 1AR and p230 localization in the boxed region. For 
all images, mCherry fluorescence was used to identify 1AR localization, rabbit anti-
golgin-160 and either mouse anti-golgin-97 or -p230 followed by labeling with Cy5 anti-
rabbit IgG and Alexa Fluor 488 anti-mouse IgG were used to determine golgin 
localization. Microscopy was performed in one (for C) or two (for A) independent 











golgin-97 continued to increase and reached a plateau 40 minutes post biotin (Figure 3-
3B). The packaging of cargo proteins at the trans-Golgi is a complex process, and part of 
this packaging can involve separating cargo proteins into subdomains based on their 
transport machinery. To see if β1AR was being specifically sorted into golgin-97 
containing subdomains, we compared the localization of β1AR to another golgin, p230. 
Like golgin-97, p230 is localized at the trans-Golgi through interaction with the small 
GTPase ARL1, however these proteins are known to localize to separate TGN 
subdomains (Gleeson et al., 2004). Using indirect immunofluorescence microscopy to 
examine the localization of β1AR and p230 during trafficking using the RUSH system, we 
did not observe any significant colocalization between the two proteins after biotin 
addition (Figure 3-3C). 
Golgin-97 does not promote anterograde trafficking of β1AR 
Golgin-97 has reported functions in both anterograde trafficking from and 
retrograde trafficking to the Golgi. We did not detect direct binding between β1AR and 
golgin-97 (data not shown), but that did not rule out indirect or transient interactions 
between these two proteins. We utilized RNAi depletion to determine which role, if any, 
golgin-97 is playing in β1AR trafficking. In HeLa cells, RNAi depletion of golgin-97 was 
variable, ranging from 65% to 80% decrease in the amount of golgin-97 protein, 
measured by Western blotting (Figure 3-4A). RNAi depletion of golgin-160 alone and 
double depletion of golgin-160 and golgin-97 were also performed, resulting in >70-80% 
depletion of each protein in each condition. 
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For each depletion condition, the amount of steady state β1AR at the plasma 
membrane was measured by indirect immunofluorescence microscopy and flow 
cytometry. By immunofluorescence, at 18 h post transfection with N-terminally FLAG-
tagged β1AR, intact cells were labeled with anti-FLAG antibody to selectively mark the 
surface pool of β1AR. Cells were then permeabilized and total β1AR was detected using 
a C-terminal antibody (Figure 3-4B). The fluorescence intensity of each signal was used 
to measure the amount of β1AR at the cell surface, which was then normalized to the 
total amount of β1AR per cell. The percent of β1AR at the plasma membrane is reported 
in Figure 3-4C. Flow analysis was also used to measure the amount of β1AR at the 
plasma membrane. HeLa cells were co-transfected with constitutive FLAG-tagged β1AR 
and cytoplasmic GFP. Live cells were immunostained with anti-FLAG and labeled with a 
phycoerythrin conjugated secondary antibody at 18 h post transfection. Flow cytometry 
analysis was then performed to assess surface expression of β1AR. The mean 
fluorescence intensity for β1AR was determined in GFP-positive cells to represent the 
average amount of β1AR at the plasma membrane and all values were normalized to 
control β1AR surface levels (Figure 3-4D). Depletion of golgin-160 led to a decrease (26% 
by immunofluorescence and flow) in the steady state surface levels of β1AR, as 
expected. Unexpectedly, depletion of golgin-97 led to an increase in surface levels of 
β1AR (27% by immunofluorescence, 13% by flow). Double depletion of golgin-160 and 
golgin-97 has a less severe defect in β1AR surface levels than golgin-160 depletion alone 
(only a 10% decrease by immunofluorescence, 20% by flow). This suggests that golgin-
97 is not promoting β1AR surface delivery as it does for E cadherin, but is instead.  
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Figure 3-4: Depletion of golgin-97 leads to an increase in β1AR steady state surface 
levels. (A) Golgin-97 and golgin-160 were either singly or double depleted from HeLa 
cells, as described in the Materials and Methods section. Separation of proteins from 
cell lysates by SDS-PAGE followed by Western blotting was performed. Membranes 
were probed with rabbit anti-golgin-160, mouse-anti-golgin-97, and mouse-anti-actin, 
followed horseradish peroxidase (HRP) conjugated secondaries and ECL. (B) 
Immunofluorescence microscopy of the surface pool of β1AR transiently transfected 
into control or golgin depleted cells. Surface β1AR (red) was detected using a mouse-
anti-FLAG antibody against the extracellular FLAG-tag on intact cells. Rabbit-anti-β1AR 
(green) was used after cells were permeabilized, followed by labeling with Alexa Fluor 
488 anti-rabbit IgG and Alexa Fluor 546 anti-mouse IgG. (C) Surface levels of β1AR were 
quantified as described in Materials and Methods. One experiment was performed for 
surface immunofluorescence of β1AR surface levels and n>30 cells were quantified, 
p<0.029 when comparing golgin-97 depletion to golgin-160 or double depletion, all 
other comparisons were not significant. (D) Flow analysis was performed on live, intact 
HeLa cells 18 h post co-transfection of constitutive FLAG- β1AR and cytoplasmic GFP. 
GFP was used to identify transfected cells, and β1AR levels were detected by flow 
analysis after immunostaining live cells with mouse anti-FLAG followed by phycoerythrin 
anti-mouse IgG. Two independent experiments were performed analyzing β1AR surface 
levels by flow cytometry. The difference between golgin-160 and double depletion was 






involved in modulating β1AR surface levels through regulation of β1AR retrograde 
trafficking  
Golgin-160 impacts dynamics of β1AR containing vesicles 
While static time points can be informative, the RUSH synchronization system 
allows for easy manipulation of cargo trafficking in conjunction with live cell imaging. In 
order to examine the influence of golgin-160 on the post-Golgi trafficking of β1AR, 
control HeLa cells or cells depleted of golgin-160 by RNAi were transfected with the 
RUSH β1AR construct. Between 20-22 h post transfection, cells were treated with biotin 
and imaged on the 3i Spinning Disk confocal microscope. To capture rapid vesicle 
trafficking, stacks encompassing the majority of the cell were taken once every 1.4-1.8 
seconds at low (40 ms) exposure to prevent photobleaching and toxicity. Vesicle 
tracking was then performed using Imaris.  
Several distinct vesicle movement phenotypes were observed in cells depleted of 
golgin-160 compared to control cells (Figure 3-5A-D). An early hypothesis for how 
golgin-160 was affecting β1AR trafficking was that β1AR containing vesicles might move 
faster towards the plasma membrane in the presence of golgin-160; however we did not 
observe this (Figure 3-5E). Instead, in the absence of golgin-160, β1AR-containing 
vesicles moved less persistently; vesicles paused at an intermediate location between 
the Golgi and plasma membrane (Figure 3-5C). After stalling, vesicles could continue in 
the same direction, or they occasionally reversed direction to return towards the cell 
center (Figure 3-5D). These differences can be seen in two measurements, track 
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displacement length and track length, as well as two calculated measurements called 
track straightness and speed variation (Figure 3-5E and F). Track displacement length 
measures the straight line distance between the beginning of the vesicle track and the 
end, whereas track length measures the total distance travelled by each vesicle. The 
track displacement was almost doubled in golgin-160 depleted cells, indicating that 
β1AR containing vesicles were moving farther away from the Golgi before reaching their 
final destination. The track length tripled, which could be due to vesicles changing 
direction. This is supported by the decrease in track straightness (Figure 3-5F), which is 
calculated by dividing the track displacement by the length, in cells depleted of golgin-
160. The vesicle pausing behavior is measured by the parameter speed variation, which 
is calculated by dividing the speed standard deviation by the average speed. As the 
speed of vesicles did not change significantly (Figure 3-5E), the increase in speed 
variation observed in golgin-160 depleted cells is due to the increase in the variability 





Figure 3-5: Live cell imaging reveals aberrant post-Golgi vesicle dynamics in cells 
depleted of golgin-160. (A) Live cell imaging of control or golgin-160 depleted HeLa cells 
transfected with RUSH β1AR were taken on a 3i Spinning Disk confocal microscope and 
vesicles were tracked using Imaris. Tracks created for representative cells from each 
condition are displayed. Tracks are color coded by vesicle speed. (B) One representative 
vesicle from the control cell is shown (white arrow) moving directly from the Golgi to 
the plasma membrane (panels go right to left). Time post biotin addition is shown in the 
top left corner of each panel. (C) One representative vesicle from the golgin-160 
depleted cell that shows vesicle pausing. The top left panel shows the overall track of 
the vesicle, for clarity. The other panels (read top to bottom) show the path of the 
vesicle (white arrow) over time. Time post biotin addition is shown in the top left. 
Images representing the end of a pause include a notation on the duration of the pause 
by the time stamp, and a vesicle that reversed direction to travel towards the cell 
interior is highlighted. (D) A track from another vesicle from the golgin-160 depleted 
cell, this one showing the vesicle reversal phenotype. Layout is as in (C). The time when 
the vesicle reverses direction highlighted. (E) The minimum and maximum vesicle speed 
as well as the track length and displacement length for the tracked vesicles were 
determined using Imaris. (F) Two calculated metrics, track straightness and speed 
variation, were calculated for each tracked vesicle. Three independent live cell imaging 
experiments were performed and 24-28 individual tracks were measured per condition, 

































The golgin family of proteins supports Golgi structure and function throughout 
the eukaryotic domain. Recently, numerous golgins have been implicated in promoting 
vesicle tethering at the Golgi. Here, we investigated the impact of three atypical golgins 
on β1AR trafficking. 
Efficient β1AR trafficking to the plasma membrane has been shown to be 
dependent on golgin-160 (Hicks et al., 2006). In investigating the mechanism behind this 
phenotype, we discovered that golgin-160 disperses from Golgi membranes in cells 
constitutively expressing β1AR (Figure 3-1A-C). Using the RUSH system to synchronize 
β1AR trafficking out of the ER, we determined the timing behind this change in 
localization in nocodazole treated cells. Golgin-160 dispersed from Golgi membranes 
after β1AR left the cis-Golgi, and returned to Golgi membranes after β1AR left the trans-
Golgi. Golgin-160 is recruited by the active, GTP-bound form of the GTPase ARF1 (Yadav 
et al., 2012). However, overexpression of the ARF1 GEF GBF1 did not prevent golgin-160 
dispersal (Figure 3-1B-C), indicating that it is unlikely that ARF1-GTP depletion at the cis-
Golgi causes the loss of golgin-160 localization, or the delay in golgin-160 recovery to 
the Golgi. We therefore hypothesize that the loss of golgin-160 binding to Golgi 
membranes is important for golgin-160 facilitated trafficking of β1AR. 
The golgin-160 targeting information resides in its N-terminus between residues 
172-257 (Hicks and Machamer, 2002), and the N-terminal domain (residues 1-496) can 
bind directly and specifically to ARF1-GTP (Yadav et al., 2012). Interestingly, this same 
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region binds to β1AR (residues 140-257, Hicks et al., 2006). This may indicate that 
golgin-160 is handed off from ARF1-GTP to β1AR upon β1AR arrival to the cis-Golgi. As 
golgin-160 is never observed to travel with β1AR into the trans-Golgi or post-Golgi 
vesicles (Figure 3-3), we hypothesize that golgin-160 is released into the cytoplasm upon 
β1AR trafficking to the medial or trans-Golgi. The delay in golgin-160 recovery to Golgi 
membranes could be due to slow diffusion kinetics, or possibly a transient masking of 
golgin-160 localization motifs. Changes to golgin-160 localization based on interactions 
with other proteins is not novel: the golgin-160 N-terminus contains a cryptic nuclear 
localization signal that is unmasked due to secretory stress-induced caspase cleavage 
(Mancini et al., 2000; Hicks and Machamer, 2002; Maag et al., 2005). While the recovery 
of golgin-160 to Golgi membranes indicates that golgin-160 is not being cleaved or 
degraded after β1AR binding, golgin-160 is a phosphorylated protein (Misumi et al., 
1997; Cha et al., 2004), and it could be imagined that changes in N-terminal 
phosphorylation (or in another post translational modification, or protein conformation) 
could result in a transient masking of the ARF1-interacting domain. 
While golgin-160 does not localize with β1AR at the TGN, β1AR does selectively 
localize with the trans-Golgi protein golgin-97, and not with p230 (Figure 3-3). Golgin-97 
was previously reported to colocalize with E cadherin in trans-Golgi tubules, and 
depletion of golgin-97 caused a reduction in E cadherin surface levels (Lock et al., 2005). 
In contrast, depletion of golgin-97 here led to a small but consistent increase in the 
steady state surface levels of β1AR (Figure 3-4C and D). Golgin-97 has also been 
implicated in tethering retrograde endosome derived vesicles to the TGN (Munro, 2011; 
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Wong and Munro, 2014); golgin-97 promoting β1AR recycling to the Golgi would be 
more consistent with the phenotype observed here.  
Delivering proteins efficiently and accurately to their final destination requires 
several complex series of protein interactions. At the TGN, cargo proteins must be 
sorted into the correct vesicle type (clathrin-dependent, -independent, or pleiomorphic 
tubule-like carriers), often through interactions with coat or adaptor proteins (Gleeson 
et al., 2004; Anitei and Hoflack, 2011). Newly formed vesicles must then be transported 
along microtubules to their destination membrane. This process often requires cargo 
adaptors, multiprotein motor adaptor scaffolds, and molecular motors. There has been 
some evidence that motor proteins can bind directly to some cargo proteins, but the 
importance of multiprotein scaffolds in linking cargo and motor is being increasingly 
highlighted (Akhmanova and Hammer, 2010). There are several known scaffolding 
proteins, including the rab7-interacting lysosomal protein (RILP) and huntingtin 
proteins.  
The initial “selective recruitment” model, in which anterograde trafficking 
vesicles would attach to plus end (cell periphery) directed kinesins and retrograde 
vesicles would bind minus end-directed dynein, was complicated by the discovery that 
many vesicles simultaneously bind to both dynein and kinesins. These led to the “tug of 
war” model, in which vesicles are constantly being pulled in opposite directions. 
However, many vesicles do not show the frequent direction reversals that such a model 
would predict. This is addressed by the “coordination model” in which both types of 
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motors are constantly attached to vesicles, but the scaffold complex regulates which 
motor is engaged. Huntingtin is an example of this model. It forms a complex that can 
bind to both dynein and kinesin, and phosphorylation of huntingtin may determine 
which motor is functional at any time (Caviston and Holzbaur, 2009; Fu and Holzbaur, 
2014). 
β1AR containing vesicles in cells depleted of golgin-160 lost their processive 
movement. Instead, they exhibited multiple pausing events and direction reversals 
(Figure 3-5C-D). This phenotype may indicate that the scaffold complex in β1AR 
containing vesicles was disrupted without golgin-160. This could be through altering the 
scaffold protein state (for example, huntingtin phosphorylation state changes vesicle 
direction) or through altering the scaffold protein’s ability to localize on the vesicle. RILP 
promotes retrograde lysosome to TGN trafficking by interacting with Rab7-GTP, which is 
activated on late endosomes, and then recruits dynein and dynactin. RILP membrane 
interaction is stabilized by another protein, ORP1L (oxysterol-binding protein-like 1), 
which is a cholesterol sensor, therefore tying scaffold and motor recruitment to the lipid 
composition of a membrane (Fu and Holzbaur, 2014). GPCR binding to Rabs or Rab-
modifying proteins has been shown to modulate GPCR endocytosis and recycling to the 
plasma membrane (Hamelin et al., 2005; O’Keeffe et al., 2008; Lachance et al., 2011), 
and Rab8 can bind to the C-terminal tail of several GPCRs to promote their anterograde 
Golgi to plasma membrane transport (Wang and Wu, 2012). 
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The mechanism behind how the cis-Golgi localized golgin-160 facilitates β1AR 
trafficking from the trans-Golgi to the plasma membrane is still unclear. We have yet to 
identify any post-translational modifications on β1AR that depend on the presence of 
golgin-160; instead, here we present data that suggests that golgin-160 is important for 
incorporating β1AR into processive, directional vesicles. This could be through altering 
the ability of β1AR to recruit multiprotein scaffolds, either directly or through other 
proteins like cargo adaptors or small GTPases. Altering interactions with these scaffold 
complexes could result in altered vesicle interactions with motor proteins, potentially 
resulting in the stalled, reversible movements of vesicles described here. Future work 
analyzing the coat and trafficking components associated with β1AR containing vesicles 
in the presence and absence of golgin-160 may provide more insight into how golgin-





Materials and Methods 
Cell Culture 
HeLa cells were maintained in DMEM (Life technologies, Grand Island, NY, USA) with 
10% Fetal Bovine Serum (Atlanta Biologicals, Flowery Branch, GA, USA) and 0.1 mg/mL 
Normocin (InvivoGen, San Diego, CA, USA) at 37 °C with 5% CO2. 
Expression constructs and transfection 
Human FLAG-β1AR cDNA in pcDNA3 was provided by Randy Hall (Emory University, 
Atlanta, GA, USA). The cytosolic GFP vector pEGFP C1 was obtained from Clontech 
(Mountain View, CA, USA). The mCherry β1AR construct was created by subcloning 
β1AR into a mCherry backbone. The RUSH GFP backbone was provided by Franck Perez 
(Institut Curie, Centre de Recherche, Paris, France). The RUSH β1AR plasmid was created 
by removing the GFP tag from the RUSH backbone and subcloning in mCherry β1AR. HA-
GBF1 was provided by Dr. Elizabeth Sztul (University of Alabama at Birmingham, 
Birmingham, AL, USA). The GBF1 coding region was subcloned into the pEGFP C1 
backbone. Plasmids were verified by sequencing. All transfections were done with X-
tremeGENE9 DNA transfection reagent (Roche, Indianapolis, IN, USA) as per 
manufacturer protocols. 
Antibodies 
Mouse monoclonal anti-FLAG and mouse-anti-mCherry were from Sigma-Aldrich (St. 
Louis, MO, USA). Rabbit anti-β1AR C terminus was obtained from Santa Cruz 
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Biotechnology (Santa Cruz, CA, USA). Rabbit anti-golgin-160 was previously described 
(Mancini et al., 2000). R-Phycoerythrin-conjugated IgG goat anti-mouse was from 
Jackson ImmunoResearch Laboratories Inc. (West Grove, PA, USA). Mouse anti golgin-97 
and mouse anti-p230 were obtained from BD Transduction Laboratories (San Jose, CA, 
USA). Alexa Fluor 568 anti-mouse IgG, Alexa Fluor 488 anti-mouse, Alexa Fluor 568 anti-
rabbit, and Alexa Fluor 488 anti-rabbit IgG were from Life Technologies. Cy5-conjugated 
AffiniPure Donkey anti-rabbit IgG was obtained from Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA, USA). Horseradish peroxidase (HRP)-conjugated 
secondary antibodies were from GE Healthcare (Little Chalfont, Buckinghamshire, UK). 
Golgin-160 dispersal  
HeLa cells grown to 70% confluence on autoclaved coverslips in 35 mm dishes were 
transfected with 0.5 ug mCherry β1AR alone, or co-transfected with 0.5 ug HA-GBF1 for 
16 h. Cells were then fixed in 3% paraformaldehyde and permeabilized in 0.02% saponin 
(CalBiochem/Sigma) and 10 mM glycine (Sigma) in phosphate buffered saline (PBS; 
Sap/PBS/gly buffer). Coverslips were incubated 15 min in anti-golgin-160 and anti-
GM130 primary antibodies diluted in Sap/PBS/gly buffer with 1% bovine serum albumin 
(BSA). Cells were washed 2 times with Sap/PBS/gly buffer before being incubated in 
Alexa Fluor 568 anti-mouse IgG and Alexa Fluor 488 anti-rabbit IgG diluted as above. Cells 
were washed again before being incubated for 3 min in 0.1 μg/mL Hoechst 33258 
diluted in PBS. Coverslips were then mounted in glycerol with 0.1 M N-propyl gallate. 
Coverslips were imaged on an Axioskop microscope (Zeiss, Thornwood, NY, USA) 
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equipped for epifluorescence using an ORCA-03G charge-coupled device camera 
(Hamamatsu, Japan) using iVision software (BioVision Technologies, Exton, PA, USA).  
To quantify dispersal, the GM130 stain was used to identify a Golgi region of interest. 
The golgin-160 fluorescence intensity within the Golgi region ROI and in an ROI 
encompassing the whole cell was then measured using FIJI (National Institutes of 
Health, Bethesda, MD, USA). The percent of golgin-160 within the Golgi region was 
calculated by dividing the Golgi intensity measurements by the whole cell 
measurements for each cell. Data was normalized to non-transfected cells imaged on 
the same coverslip by dividing the individual values for percent at the Golgi by the 
average non-transfected percent at the Golgi. In the box and whisker plot, the center 
bar represents the mean, the box extends from the 25th to the 75th percentiles, and the 
whiskers extend to the minimum and maximum values. Data are from two independent 
experiments; 39-43 cells were quantified for each condition. 
β1AR Trafficking Time Course 
HeLa cells plated on coverslips in 35 mm dishes were transfected with 0.5 ug RUSH 
β1AR. After 18 h, cells were pre-treated with 1 ug/mL nocodazole for 2 h before 10 uM 
biotin was added for the indicated amount of time. Cells were then fixed and 
permeabilized in saponin as described above. Cells were incubated in anti-golgin-160 
and either anti-golgin-97 or anti-p230 primary antibodies. Cy5 anti rabbit and Alexa 
Fluor 488 anti-mouse were used to label the golgins, and mCherry fluorescence was 
used to identify β1AR localization. Imaging was performed as described above. 
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Quantification of Pearson’s R coefficient to measure colocalization was done using the 
Coloc 2 plugin on FIJI. Only early time points were measured for colocalization, as signal 
from plasma membrane localized β1AR at 80 min post-biotin addition covered the 
entire cell, artificially increasing the colocalization coefficient by appearing to 
“colocalize” with Golgi structures.  
Double depletion analyses 
Synthetic siRNA-4 duplex for golgin-160 depletion was obtained from Dharmacon 
Research Inc. (Lafayette, CO, USA) and was previously described (Hicks et al., 2006). 
Control scramble (SR30005) and golgin-97 (GOLGA1 SR301868A) Trilencer-27 siRNA 
constructs were obtained from OriGene (Rockville, MD, USA). HeLa cells were plated on 
35 or 60 mm dishes 6-8 hours prior to siRNA addition. A final concentration of 13.5 nM 
siRNA-4 was mixed with 5 nM g97 A RNA. For single depletion experiments and for 
controls, scrambled RNA was added to make up a final concentration of 18.5 nM (13.5 + 
5 nM). Cells were transfected with Oligofectamine (Invitrogen, Carlsbad, CA, USA) 
according to manufacturer protocols for 18-20 hours. Fresh media was added and cells 
were grown for an additional 24 h. Experimental dishes were then plated from the initial 
knockdown plates. For each experiment, one 35 mm dish was plated at 3x105 cells/mL 
for lysates to compare depletion effectiveness. After 48 h, cells were lysed in detergent 
solution (1% NP-40, 0.4% deoxycholic acid, 50 mM Tris pH 8, 62.5 mM EDTA pH 8 with 
protease inhibitors) and proteins were separated by SDS-PAGE. Golgin-160, golgin-97, 
and actin were detected by immunoblotting with antibody against each protein 
followed by ECL. The amount of each protein in each sample was measured after 
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imaging on a VersaDoc Imaging System Model 5000 (Bio-Rad, Hercules, CA, USA) using 
Quantity One volume analysis tools (Bio-Rad, Hercules, CA, USA). Percent depleted was 
calculated after first normalizing each sample to actin, and then values were normalized 
to the control sample. 
Surface Immunofluorescence 
For RUSH β1AR surface immunofluorescence experiments, cells at 70% confluency on 
coverslips in 35 mm dishes were transfected with 0.5ug RUSH β1AR. After 20 h 
transfection, 10 uM biotin, from a 40 mM stock diluted in serum free DMEM and 0.22 
μm filter sterilized, was added to cells for the time indicated. After the indicated amount 
of time, cells were incubated on ice in anti-mCherry diluted in cold PBS for 15 min. Cells 
were then fixed in 3% paraformaldehyde for 10 min and permeabilized in 0.05% Triton 
X-100 for 3 min. Cells were washed in PBS/gly, (the Sap/PBS/gly buffer described above 
without saponin) for 5 min then incubated for 15 min in anti- β1AR antibody diluted in 
1% BSA in PBS/gly. Cells were washed in PBS/gly and then incubated in Alexa Fluor 488 
anti-mouse IgG and Alexa Fluor 568 anti-rabbit IgG, diluted in 1% BSA in PBS/gly as above. 
Nuclei were stained with Hoechst 33258 and images were taken as described above. 
For golgin depletion experiments, cells were plated on coverslips in 35 mm dishes. 24 
hours after plating, cells were transfected with 0.5 ug FLAG-β1AR. After 16 h, cells were 
washed with ice cold PBS and stained with mouse anti-FLAG for 15 min in 1% BSA in PBS 
on ice. Cell fixation, permeabilization, and internal primary antibodies were done the 
same as the RUSH β1AR surface immunofluorescence. Cells were washed in PBS/gly and 
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then incubated in Alexa Fluor 568 anti-mouse IgG and Alexa Fluor 488 anti-rabbit IgG, 
diluted as above. Nuclei were stained with Hoechst 33258 and images were taken as 
described above. Surface fluorescence was measured by measuring the fluorescence 
intensity of each cell for each image, and dividing the surface intensity by the total 
intensity. Data were normalized to control cells by dividing individual cell percent at the 
surface by the average percent from control cells. 
Flow Analysis of β1AR Surface Levels 
For flow analysis, three 60 mm dishes were plated per condition. After 24 h, cells were 
co-transfected with 1.5 ug cytosolic GFP and 0.5 ug FLAG β1AR. After 16 hr expression, 
cells were harvested by trypsinization and washed twice with DMEM. Cells were 
resuspended at 5x106 cells/mL in blocking solution (1% BSA in PBS) and incubated for 30 
min on ice. Cells were then incubated for 1 h on ice with anti-FLAG antibody diluted in 
blocking solution. Cells were washed in cold PBS and were then incubated 1 h on ice in 
phycoerythrin-labeled goat anti-mouse IgG diluted in blocking solution. After a final 
wash in cold PBS, cells were resuspended in serum free DMEM and analyzed using the 
FACSCalibur flow cytometer (Becton Dickinson, Franklin Lake, NJ, USA). The mean 
phycoerythrin fluorescence intensity of cells expressing GFP was calculated for each 






Live cell imaging and vesicle tracking 
HeLa cells were plated on uncoated 35 mm glass bottom dishes No. 1.0 (MatTek 
Corporation, Ashland, MA, USA). After 24 h, cells were transfected with RUSH mCherry-
β1AR for 20 h. Immediately before imaging, 10 μM biotin was added to the dishes. 
Imaging was done on a 3i Marianis/Yokogawa Spinning Disk Confocal microscope 
outfitted with an environmental chamber heated to 37oC with 5% CO2. Images were 
taken once every 1.4-1.8 seconds at low (40 ms) exposure. Between 4-10 cells were 
imaged per dish and were selected based on similar, moderate β1AR expression level. 
Each cell could be imaged for 7-15 min before photobleaching and phototoxicity 
impeded analysis. Vesicle tracking was performed on Imaris 8.1 (Bitplane, Oxford 
Instruments, Zurich, Switzerland). Two cells were selected for vesicle tracking based on 
ability to reliably track vesicles from Golgi to the plasma membrane. Manual tracking 
was performed using the Imaris spot detection and tracking tools. For golgin-160 
depleted cells, 28 vesicles were tracked; 24 were tracked for control cells. The metrics 
described in Figure 3-5 were measured using the Imaris spots tracking tool. 
Statistical Analysis 
Statistical analyses were obtained using GraphPad Prism version 7.00 for Mac OS X 
(GraphPad Software, La Jolla, CA, USA). For all experiments, one-way ANOVA followed 












Commonly used trafficking blocks disrupt ARF1 activation and the 
localization and function of specific Golgi proteins 
 





The ARF family of proteins consists of five small GTPases that are critical for the 
function of the secretory pathway through their interactions with effector proteins 
(reviewed in D’Souza-Schorey and Chavrier, 2006; Donaldson and Jackson, 2011). The 
ARFs play semi-redundant but essential roles in cargo transit throughout the secretory 
system through their functions as molecular switches, which result from their GTPase 
cycles (Volpicelli-Daley et al., 2005). The cis-Golgi role of ARF1 has been well studied. 
After activation by its guanine nucleotide exchange factor (GEF), GBF1, the Golgi 
membrane-bound ARF1-GTP recruits COPI coat complexes to interact with cargo 
proteins (reviewed in Jackson, 2014). The ARF GTPase activating protein (ARFGAP)-
stimulated hydrolysis of GTP by ARF1 is required for the recruitment of cargo into COPI 
coated vesicles and the subsequent removal of those coats (Teal et al., 1994; Nickel et 
al., 1998; Pepperkok et al., 2000; Lee et al., 2005).  
ARF1-GTP can recruit several other effector proteins, one of which is golgin-160 
(also called GOLGA3 and GCP-170). Found only in vertebrates, golgin-160 has been 
reported to promote Golgi structure as well as facilitate the proper targeting and 
efficient trafficking of specific cargo proteins (Hicks et al., 2006; Yadav et al., 2009). 
Many golgins promote bulk cargo movement through the Golgi, by acting as tethers or 
maintaining Golgi structure (Munro, 2011). Golgin-160’s trafficking role is unique 
because it only promotes the trafficking of a small, specific subset of cargos. We 
previously found that loss of golgin-160 causes GLUT4 to traffic directly to the plasma 
membrane, bypassing its proper localization to insulin sensitive vesicles (Williams et al., 
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2006). We also reported that golgin-160 directly binds to the beta-1 adrenergic receptor 
(β1AR), and that depletion of golgin-160 decreases β1AR steady state surface levels as 
well as the rate of arrival of the receptor at the plasma membrane (Hicks et al., 2006; 
Gilbert et al., 2014). Intriguingly, the cis-localized golgin-160 affects the rate of β1AR 
trafficking at a post-trans-Golgi step (Hicks et al., 2006). These findings led us to become 
interested in how the localization of golgin-160 impacted its function in protein 
trafficking.  
Synchronization of cargo exit from a specific compartment is a commonly used 
tool to study protein trafficking at distinct stages of the secretory pathway. Several new 
synchronization techniques have been developed in the last several years, however they 
require protein modifications which can have unintended effects on trafficking or 
localization (reviewed in Boncompain and Perez, 2013; Roboti et al., 2013; Feng and 
Arnold, 2016). One of the oldest and most broadly useful techniques is the use of cold 
temperature blocks, which allows for synchronization of untagged, endogenous cargo 
proteins. First reported in 1983, it was shown that incubating cells at 20oC leads to a 
total block in cargo trafficking at the trans-Golgi network (TGN), while an incubation at 
15-16oC leads to retention of cargo proteins in the early Golgi or ER-Golgi intermediate 
compartment (ERGIC; Matlin and Simons, 1983; Saraste and Kuismanen, 1984; Saraste 
and Svensson, 1991). While some data, like the inability of brefeldin A (BFA) to collapse 
the Golgi into the ER at these temperatures (Lippincott-Schwartz et al., 1990), suggest 
that these blocks may be due to inhibiting membrane dynamics, the exact mechanism 
behind these temperature blocks has never been elucidated. 
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In this study, we attempted to utilize cold temperature blocks to study golgin-
160’s role in cargo trafficking at distinct compartments of the secretory pathway. 
However, we found that these temperatures disrupt golgin-160 localization at the Golgi. 
This led us to analyze the effects of cold temperature shifts on ARF1 (the protein 






Golgin-160 disperses from Golgi membranes in cells subjected to 20 or 16oC trafficking 
blocks 
We and other groups have reported that golgin-160 facilitates the trafficking of 
specific cargo proteins (Bundis et al., 2006; Hicks et al., 2006; Williams et al., 2006; 
Gilbert et al., 2014). To dissect golgin-160’s role in this process, we attempted to employ 
two commonly used temperature blocks to stop cargo trafficking at different 
subcompartments of the Golgi complex. However, when we assessed the localization of 
golgin-160 by indirect immunofluorescence microscopy in HeLa cells after incubation for 
3 h at 20 or 16oC, we found that golgin-160 signal was lost from the Golgi region (Fig. 4-
1A). To quantify this effect, we defined the Golgi region using the fluorescence of 
another cis-Golgi-localized peripheral membrane protein, GM130, and measured the 
golgin-160 fluorescence intensity within both the Golgi region and the whole cell. The 
percent of the signal within the Golgi region was calculated and the values were 
normalized to those in cells kept at 37oC. Surprisingly, there was a progressive loss of 
golgin-160 localization at the lower temperatures, with a 40% decrease in golgin-160 at 
the Golgi at 20oC, and a 48% decrease at 16oC (Figure 4-1B). 
It was possible that the loss of Golgi-localized golgin-160 could be due to protein 
degradation. However, a Western blot of lysates from HeLa cells incubated at 37, 20, or 





Figure 4-1: Two temperature blocks lead to dispersal of golgin-160 from Golgi 
membranes. (A) Representative images of HeLa cells incubated for 3 h at 37, 20, or 16oC 
for 3 h are shown. Cells were labeled with rabbit anti-golgin-160 and mouse anti-
GM130, followed by AlexaFluor488 anti-rabbit IgG and Alexa Fluor 546 anti-mouse IgG. 
Scale bar, 10 μm. (B) Quantification of golgin-160 dispersal. The GM130 signal was used 
to outline the Golgi region in each cell, and the amount of golgin-160 fluorescent signal 
was calculated within the Golgi and divided by the total golgin-160 fluorescence in the 
cell to obtain the percent of golgin-160 at the Golgi. Each fluorescence intensity value 
was normalized to that at 37oC.  More than 160 cells from 3 separate experiments were 








Figure 4-2: Loss of golgin-160 localization at cold temperatures is not due to protein 
degradation. (A) Lysates of HeLa cells incubated at 37, 20, or 16oC for 3 h were analyzed 
by Western blot with rabbit anti-golgin-160 or mouse anti-actin, followed by 680RD 
donkey anti-rabbit IgG or 680RD donkey anti-mouse IgG. (B) Golgin-160 signal was first 





Thus, it appears that cold temperatures cause the release of golgin-160 from the 
membranes into a cytosolic pool. 
Manolea et al. discovered that exogenously expressed GFP-tagged ARF3 loses its 
Golgi localization upon shifting cells to 20oC. This relocation to the cytoplasm was nearly 
complete within 20 minutes, and ARF3 Golgi localization could be restored within 20 
minutes of shifting cells back to 37oC (Manolea et al., 2010). Thus, we examined the 
kinetics of golgin-160 dispersal, and whether the effect was reversible. Golgin-160 
dispersal was not as rapid as that reported for ARF3: after 30 minutes at 16oC, Golgi 
localized golgin-160 decreased by only 32%, compared to 48% after 3 h (Figure 4-3). 
Golgin-160 localization also recovered more slowly than that of ARF3: when HeLa cells 
incubated for 3 h at 16oC were shifted back to 37oC for 30 minutes, golgin-160 still had a 
12% decrease in Golgi localization compared to cells kept at 37oC for the entire time 
course (Figure 4-3B).  
ARF1 activation status but not its localization is altered at cold temperatures 
Golgin-160 localization at the Golgi is dependent on the activation status of the 
small GTPase ARF1 (Yadav et al., 2012). We predicted that the temperature blocks might 
cause golgin-160 dispersal by affecting ARF1 activation. Thus, we determined the 
relative amount of GTP-bound ARF1 in HeLa cells incubated at 37, 20, or 16oC using an 
effector GGA3-based pull down kit (see Materials and Methods). We observed a 30% 
decrease in the amount of GTP-bound ARF1 in cells incubated for 3 h at 20oC, and a 60% 





Figure 4-3: Golgin-160 disperses from and recovers to the Golgi slowly during 
temperature shifts. (A) HeLa cells were shifted from 37oC to 16oC for 0, 0.5 or 3 h. For 
recovery, cells were incubated 3 h at 16oC and then returned to 37oC for 0.5 h. Cells 
were labeled with rabbit anti-golgin-160 and mouse anti-GM130, followed by 
AlexaFluor488 anti-rabbit IgG and Alexa Fluor 546 anti-mouse IgG. Scale bar, 10 μm. (B) 
Quantification of the percent of golgin-160 signal in the Golgi region was calculated as in 
Figure 4-1. More than 170 cells from 3 separate experiments were analyzed for each 




incubation at 16oC, a 30 minute recovery at 37oC restored levels of activated ARF1, with 
only an 11% decrease in ARF1-GTP levels compared to control cells maintained at 37oC. 
We observed a wide range of biological variability in this assay, but the progressive loss 
of GTP-bound ARF1 at cold temperatures and the ability to restore ARF1-GTP levels after 
a recovery period correlated with the progressive decrease and restoration of Golgi-
localized golgin-160 (Figure 4-1B and 4-3B). 
Manolea et al. (2010) also examined the localization of GFP-tagged ARF1 at 20oC 
and found that ARF1, unlike ARF3, was insensitive to this temperature shift and did not 
dissociate from the Golgi. We confirmed that GFP-tagged ARF1 does not disperse from 
Golgi membranes at 20oC, and also observed no change in GFP-ARF1 localization at 
16oC, despite the decrease in cellular ARF1-GTP levels (Figure 4-4C).  
While activated ARF1-GTP is canonically the predominant form of ARF1 thought 
to be stably associated with Golgi membranes, the dominant inactive ARF1 T31N mutant 
(that mimics the inactive ARF1-GDP) is also Golgi localized, possibly through stabilized 
interaction with GBF1 (Niu et al., 2005; Szul et al., 2005). The Golgi localization of ARF1-
GFP observed by fluorescence microscopy at cold temperatures, coupled with the 
decrease in cellular ARF1-GTP levels, suggest that the Golgi-localized ARF1 could be 
stabilized on Golgi membranes in its GDP bound form. This predicts that the decrease in 
golgin-160 localization should be prevented by providing activated ARF1 to the cells. To 
test this, we expressed the ARF1 Q71L mutant, which mimics the active ARF1-GTP 
bound protein (Teal et al., 1994). ARF1 Q71L prevented golgin-160 dispersal at both 







Figure 4-4: ARF1-GTP levels decrease during cold temperature shifts and recover after 
return to 37oC, but GFP-ARF1 localization does not change. (A) Representative Western 
blot of active (GTP-bound) ARF1. The input and pull down (PD) samples were run side by 
side. HeLa cells were incubated at 37, 20, or 16oC for 3 h before being lysed. For the 
recovery sample, cells were incubated at 16oC for 3 h before being shifted back to 37oC 
for 0.5 h. Active ARF1 was removed from lysates using agarose beads conjugated with 
the ARF1-GTP binding domain of GGA3. (B) The amount of active ARF1 was analyzed by 
Western blot and was normalized first to input and then to the 37oC control. For the 
recovery time point n=3; n=5 for all other conditions. When analyzed using an ANOVA 
and post hoc Tukey test, p=0.08 comparing 37oC and 16oC, p>0.2 for all other 
comparisons. (C) HeLa cells expressing GFP-ARF1 WT for 16-17 h were shifted to 20 or 












decrease in golgin-160 Golgi localization by 28 and 44%, ARF1 Q71L transfected cells had 
reductions of only 11 and 26%, respectively (Figure 4-5B). Thus, it appears that the cold-
induced dissociation of golgin-160 from Golgi membranes is due to reduced levels of 
ARF1 activation. 
Cold temperatures affect the function of the ARF1 activator GBF1  
GBF1 depletion experiments have indicated that GBF1 is required for ARF1 
activation to facilitate golgin-160 recruitment (Yadav et al., 2012). Thus, we examined 
the distribution of endogenous GBF1 in cells incubated at lower temperatures. As shown 
in Figure 4-6A, GBF1 displayed increased Golgi localization at 20oC and 16oC. The 
increased level of Golgi-associated GBF1 is consistent with the Golgi-localized ARF1 
being in an inactive form as GBF1 is stabilized on membranes in the presence of the 
ARF1-GDP, and is released from membranes when ARF1 becomes activated by binding 
GTP (Szul et al., 2005). The increased localization of GBF1 and inactive form of ARF1 at 
the Golgi during cold treatments suggests that the catalytic activity of GBF1 might be 
inhibited at lower temperatures. 
To further probe this point, we expressed GFP-tagged GBF1 and assessed its 
ability to support golgin-160 localization in the cold. We did not observe any protective 
effect of overexpressing GBF1 on golgin-160 dispersal at lower temperatures (Figure 4-
6B). When normalized to cells incubated at 37oC, the Golgi localization of golgin-160 
decreased by ~27 and ~41% at 20oC and 16oC, respectively, in both GBF1 transfected 






Figure 4-5: The active ARF1 Q71L mutant can prevent golgin-160 dispersal from the 
Golgi at lower temperatures. A) HeLa cells expressing GFP-ARF1 Q71L for 16-17 h were 
shifted to 20 or 16oC for 3 h. GFP fluorescence was used to identify transfected cells and 
golgin-160 and GM130 localization was determined by indirect immunofluorescence 
with rabbit anti-golgin-160 and mouse anti-GM130, followed by AlexaFluor488 anti-
rabbit IgG and Cy5 anti-mouse IgG. Scale bar, 10 μm. Arrows indicate transfected cells. 
B) The percent of golgin-160 at the Golgi was calculated in both transfected (T) and non-
transfected (NT) cells for each experiment as described in Figure 4-1.  For each 
population of cells (T and NT), values were normalized to 37oC.  The differences 
between temperatures were significant for both T and NT populations (p<0.001 for all 
comparisons). Expression of ARF1 Q71L was protective, with a significant difference 
between ARF1 Q71L transfected and non-transfected cells at both 20oC and 16oC 
(p<0.001). More than 135 cells from 4 separate experiments were analyzed for each 














Figure 4-6: GBF1 overexpression does not prevent golgin-160 dispersal from the Golgi 
at lower temperatures. (A) HeLa cells were shifted to 20 or 16oC for 3 h, followed by 
staining with mouse anti-GBF1 and AlexaFluor 546 anti-mouse IgG. Scale bar, 10 μm. 
Arrows indicate transfected cells. (B) HeLa cells expressing GFP-GBF1 A795E for 16-17 h 
were shifted to 20 or 16oC for 3 h. Microscopy and analysis was performed as in Figure 
4-5B) The differences in golgin-160 Golgi localization between temperatures were 
significant (p<0.001 for all comparisons), however there were no significant differences 
between the GBF1 transfected and NT populations at each temperature. More than 135 











Golgi at cold temperatures, is not functioning to promote conversion of ARF1-GDP to its 
GTP bound form. 
Numerous Golgi localized proteins have disrupted localization at cold temperatures 
Our finding of decreased ARF activation at lower temperatures led us to examine 
the distribution of other ARF-dependent as well as ARF-independent Golgi proteins at 
20oC and 16oC. β-COP is a subunit of the COPI coat complex, which is recruited by 
activated ARF1 to the cis-Golgi (Donaldson et al., 1992). Unexpectedly, and in contrast 
to golgin-160, β-COP had slightly increased Golgi localization at 20oC and 16oC (Figure 4-
7A). This was surprising since increased Golgi localization of β-COP has been reported 
with an increase in activated ARF1 (Teal et al., 1994; Saitoh et al., 2009). β-COP could 
also be detected in large extra-Golgi puncta at lower temperatures (Figure 4-7A). 
Punctate β-COP and altered ARF GTPase activity have previously been associated with 
punctate GM130 and ERGIC53 (Volpicelli-Daley et al., 2005; Saitoh et al., 2009), but 
those phenotypes were not observed here (Figures 4-1 and 4-7B, respectively).  
Cold-induced changes in cellular localization extend beyond the ARF-dependent 
protein family, as multiple ARF-independent proteins also had altered localization in the 
cold (Table 4-1 and Supplemental Figure 4-1). While we do not currently know how 
these proteins are affected by cold temperature shifts, our data suggest that caution 









Figure 4-7: β-COP but not ERGIC53 has altered localization in the cold. HeLa cells were 
shifted to 20 or 16oC for 3 h, followed by staining with either (A) mouse anti-β-COP or 




Protein Name Localization ARF Dependent? Change at lower temperatures? 
ERGIC53 ERGIC No No change 
Golgin-160 CGN ARF1 Decrease 
β-COP CGN ARF1 Increase; puncta at 20oC 
GBF1 CGN and TGN No Increase 
p115 CGN No No change 
GM130 CGN No No change 
Giantin Medial No No change 
AP-1 TGN ARF1/3 Increase 
GGA2 TGN ARF1/3 No change 
GGA3 TGN ARF1/3 Increase at 20oC 
BIG1 TGN ARF4/5 No change 
BIG2 TGN ARF4/5 Decrease at 16oC 
Golgin-97 TGN No Puncta 
GCC1 TGN No Variable decrease 
GCC2 TGN No No change 
p230 TGN No Increase; puncta 
Table 4-1: Numerous Golgi-localized proteins show disrupted localization patterns during cold 
shifts. Multiple Golgi-localized proteins were analyzed by indirect immunofluorescence 
microscopy after incubation at 37, 20, or 16oC for 3h. Sub-Golgi localization and ARF 
dependence does not correlate to cold shift phenotypes. TGN, trans-Golgi network; CGN, cis-





 We previously reported that golgin-160 is a cis-Golgi concentrated golgin that 
facilitates the post-Golgi trafficking of several specific cargo proteins (Hicks et al., 2006; 
Williams et al., 2006; Gilbert et al., 2014). In our attempts to further characterize the 
function of golgin-160, we utilized two common cold temperature blocks to synchronize 
protein trafficking. We report here that these temperature blocks lead to the disruption 
of not only golgin-160’s localization (Figure 4-1), but the localization and function of 
multiple Golgi resident proteins, including ARF1, several ARF1-dependant proteins and 
numerous ARF1-independent proteins (Figure 4-7, Table 4-1, and Supplemental Figure 
4-1). 
ARF1 has many effector proteins, including golgin-160, which facilitate ARF1’s 
critical roles in promoting anterograde and retrograde trafficking at the Golgi. At the cis-
Golgi, the balance between the active ARF1-GTP and the inactive ARF1-GDP is 
maintained both by its GEF, GBF1, and multiple GAPs. Disruption of this balance has a 
negative impact on trafficking through the secretory pathway: overexpression of the 
activated Q71L mutant and the triple depletion of the semi-redundant ARFGAP1, 2, and 
3 both lead to blocks in trafficking through the Golgi (Zhang et al., 1994; Claude et al., 
1999; Saitoh et al., 2009). It has been reported that wild-type ARF1 and the active ARF1 
Q71L mutant can bind to the N-terminus of golgin-160 in vitro (Yadav et al., 2012), 
which contains its Golgi targeting information (Hicks and Machamer, 2002). Here, we 
demonstrated that the degree and timing of dispersal of golgin-160 from Golgi 
membranes directly correlates with the ARF1-GTP levels in cells (Figures 4-1, 4-3, and 4-
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4). This suggests the possibility that in addition to causing the dispersal of golgin-160, a 
decrease in ARF1 activity could cause the block in protein transport observed at cold 
temperatures. However, it is likely not the only contributing factor. The BFA-induced 
collapse of the Golgi into the ER is blocked at 20oC and 16oC, which indicates that 
decreased membrane dynamics also could be impacting vesicle or cisternae fission and 
fusion events (Lippincott-Schwartz et al., 1990).  
Typically, only GTP-bound ARF1 has high membrane affinity, therefore the 
decrease in ARF1-GTP at cold temperatures should correlate with a loss of Golgi 
localized ARF1. However, we saw no changes in ARF1-GFP localization in the cold (Figure 
4-4). These data agree with the finding described by Manolea et al. (2010), where the 
cold induced dispersal of ARF3 was due to two unique amino acids in the ARF3 N-
terminus. The corresponding amino acids on ARF1 had in fact previously been 
implicated in stabilizing ARF1 contact with membranes (Antonny et al., 1997), and 
substituting these ARF1 residues with those from ARF3 caused ARF1 to gain 
temperature sensitivity (Manolea et al., 2010). Therefore, we propose that ARF1 
localization is separable from its nucleotide binding status at cold temperatures, 
possibly due to stabilized interactions between the ARF1 N-terminus and Golgi 
membranes. Furthermore, stabilized ARF1-GDP on Golgi membranes is not unique to 
cold temperatures. ARF1-GDP is bound by GBF1 on Golgi membranes, and both 
inhibition of GDP release from or GTP incorporation into ARF1 lead to stabilized ARF1-
GBF1 interactions on Golgi membranes (Szul et al., 2005). This stabilized interaction 
could explain the increased GBF1 Golgi localization in the cold (Figure 4-6). We 
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hypothesize that increased GBF1 does not lead to increased levels of ARF1-GTP because 
GBF1 is inactive at these temperatures. This was demonstrated by the observation that 
overexpression of GBF1 does not prevent golgin-160 dispersal (Figure 4-6), whereas 
directly expressing the active ARF1 mutant, ARF1 Q71L, can protect golgin-160 from 
cold-induced dispersal (Figure 4-5).  
ARFGAPs also play a role in regulating ARF nucleotide state. While we have not 
investigated the multiple ARFGAPs reported to act on ARF1, the ARF1 GTPase cycle 
could be affected by inhibition of ARFGAPs in conjunction with inhibition of ARF GEFs at 
cold temperatures; it would not be surprising that multiple enzymes are inhibited at 
lower temperatures. Decreased ARFGAP activity could explain the stabilized β-COP 
localization at the Golgi (Figure 4-7), as ARFGAP-stimulated ARF1 GTPase activity is not 
required for the initial COPI coat recruitment to the Golgi, only for cargo-containing 
vesicles to be formed (Teal et al., 1994; Nickel et al., 1998; Lee et al., 2005). Punctate β-
COP localization similar to that seen in Figure 4-7 has been reported in two opposing 
conditions: increased active ARF1-GTP due to triple depletion of ARFGAP1, 2, and 3 and 
loss of ARF1 due to double depletion of ARFs (both ARF1 and ARF3, and ARF1 and ARF5) 
(Volpicelli-Daley et al., 2005; Saitoh et al., 2009). However, all depletion experiments 
resulted in additional phenotypes not observed here, notably ERGIC53 and GM130 
puncta. We hypothesize that a simultaneous decrease in the activity of both the 
ARFGAPs and GBF1 could result in both β-COP being maintained on vesicle coats and 
Golgi membranes, and a decrease in the levels of ARF1-GTP. Interestingly, two other 
papers that examined Golgi protein localization in the cold reported increased ERGIC-53 
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Golgi localization and loss of β-COP from membranes at 15oC (Klumperman et al., 1998 
and Martínez-Alonso et al., 2005, respectively). These various discrepancies could be 
due to several factors, including differences between acutely reducing protein function 
as demonstrated here (Figure 4-4A-B), depletion of protein over several days (Volpicelli-
Daley et al., 2005; Saitoh et al., 2009), and differences in cell types used and 
methodology (Klumperman et al., 1998; Martínez-Alonso et al., 2005). It could also 
indicate that the stabilization of β-COP on the Golgi and in extra-Golgi puncta observed 
here may be through a more complex mechanism that we have yet to fully understand. 
In addition to golgin-160, other ARF-dependent proteins have altered 
localization during cold shifts (Table 4-1). Like β-COP, multiple coat proteins had 
increased Golgi localization at cold temperatures. Intriguingly, we found that the trans-
Golgi clathrin coat adaptor complex and ARF effector AP-1, like β-COP, had increased 
Golgi localization at cold temperatures (Table 4-1 and Supplemental Figure 4-1). As ARF3 
(which has a semi-redundant role in vesicle coating and trafficking at the trans-Golgi 
with ARF1; Shin et al., 2004; Dong et al., 2010) is most likely dissociated from the Golgi 
at these temperatures (Manolea et al., 2010), and we have shown here that ARF1 has 
decreased activity (Figure 4-4), we would predict that AP-1 would have decreased Golgi 
localization in the cold. It has been shown, however, that AP-1 binding to a cargo sorting 
signal enhances subsequent cargo binding and stabilizes AP-1 binding to ARF1-GTP (Lee 
et al., 2008). The high concentration of cargo proteins induced by trapping cargo at the 
trans-Golgi, in addition to altered Golgi membrane dynamics, may allow for stable 
association of cargo adaptors like AP-1 on Golgi membranes even when levels of ARF1-
124 
 
GTP are reduced. This cargo-induced or -stabilized recruitment of coat proteins is not 
unique to AP-1. GGA2 and GGA3 are two trans-Golgi localized proteins which also have 
enhanced recruitment to the Golgi in the presence of overexpressed cargo, even in the 
presence of BFA when ARF1 should be inactive (Hirst et al., 2007). Interestingly, GGA2 
localization does not change in the cold, while GGA3 has increased Golgi localization 
only at 20oC (Table 4-1 and Supplemental Figure 4-1). The GGA3 localization phenotype 
could be due to cargo being trapped at the trans-Golgi at 20oC, compared to at the cis-
Golgi at 16oC, though why it is different from GGA2 has yet to be explored.   
Several of the proteins examined in Table 4-1 with altered localization in the cold 
are recruited to the Golgi independently of ARF activity. This indicates that multiple 
mechanisms or regulators of protein localization may be impacted by cold temperature 
shifts. What is particularly interesting is that proteins that contain similar localization 
signals (e.g. the GRIP domain containing proteins golgin-97, p230, GCC1, and GCC2) 
have distinct localization phenotypes at cold temperatures. Previous work examining 
Golgi structure at cold temperatures demonstrated that glycosylation enzymes and 
several SNARE and Rab proteins involved in intra-Golgi transport rapidly localized to 
Golgi-derived tubules in cells shifted to 15oC, as well (Martínez-Alonso et al., 2005, 
2007a, 2007b). Overall, these data support the idea of a complex system of protein and 
membrane interactions being disturbed at lower temperatures. 
Cold temperature trafficking blocks are undeniably useful due to their ability to 
stop all cargo proteins in specific subcompartments of the Golgi complex, which is why 
they are still in use 3 decades after their initial discovery (Park et al., 2011; Lavieu et al., 
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2013, 2014; Jensen et al., 2014; Farr et al., 2015). However the effect of these blocks on 
Golgi function itself has not been studied in depth. While we cannot state that a 
decrease in GBF1 or ARFGAP function is the sole mechanism by which these trafficking 
blocks work, altering the activity of ARF1 has been associated with complete cargo 
trafficking blocks (Zhang et al., 1994; Saitoh et al., 2009). The effects of the cold 
temperature blocks on golgin-160 localization are reversible; however while cargo 
trafficking immediately restarts at permissive temperatures, it takes more than 30 
minutes for golgin-160 to completely recover its Golgi localization. Therefore, the 
trafficking roles of mislocalized proteins like golgin-160 may not be fully reconstituted 
immediately after return to 37oC.  
Though more specialized in scope, several new techniques to synchronize cargo 
trafficking have been developed in the past few years. The RUSH system can block a 
protein of interest in a specific secretory compartment (Boncompain et al., 2012), the 
IM-LARIAT system combines optogenetics and protein aggregation to reversibly 
sequester vesicles and inhibit trafficking at various stages throughout the secretory 
system (Nguyen et al., 2016), and the CUTE system controls cargo movement by 
reversible masking of transport signals (Abraham et al., 2016). Additionally, 
improvements in microscopy and photoactivatable constructs allow for visual pulse 
chases to be performed in cells. Genetic editing techniques are also allowing for the 
introduction of tagged proteins that are expressed at endogenous levels. These 










Supplemental Figure 4-1: Numerous ARF-dependent and -independent proteins have 
disrupted localization patterns during cold shifts. Multiple Golgi-localized proteins 
were analyzed by indirect immunofluorescence microscopy after incubation at 37, 20, or 
16oC for 3h. The cells were labeled with primary antibodies, as described in the 
Materials and Methods section, followed by Alexa Fluor 488 anti-rabbit IgG or Alexa 
Fluor 546 anti-mouse IgG. Scale bar, 10 μm. Proteins have been categorized by their 









Materials and Methods 
Cell Culture 
HeLa cells (ATCC CCL-2) were maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Life technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine 
serum (Atlanta Biologicals, Flowery Branch, GA, USA) and 0.1 mg/mL Normocin 
(InvivoGen, San Diego, CA, USA) at 37oC with 5% CO2. The cells were authenticated by 
STR profiling in the Johns Hopkins Genetics Resources Facility, and are tested for 
mycoplasma contamination every 6 months. 
Expression Constructs and Transient Transfection 
The plasmid encoding GFP-ARF1 WT was obtained from Addgene (#39554; Cambridge, 
MA, USA). The Q71L mutation was introduced via Quikchange mutagenesis and 
confirmed by sequencing (Stratagene, La Jolla, CA, USA), using the following mutagenic 
primers: 5’-GACGTGGGTGGCCTGGACAAGATCCGG-3’ and its complement, 5’-
CCGGATCTTGTCCAGGCCACCCACGTC-3’. The Venus-GBF1 A795E construct was 
previously described (Lanke et al., 2009). The A795E mutation provides resistance to 
BFA but otherwise this construct behaves similarly to WT (Lanke et al., 2009). The GBF1 
A795E coding region was subcloned into the pEGFP N1 backbone (Clontech, Mountain 
View, CA, USA). 
Transfection was performed using the X-tremeGENE 9 DNA transfection reagent (Roche, 
Indianapolis, IN) in accordance with the manufacturer’s protocol. For all transfection 
experiments, 35 mm dishes of HeLa cells were transfected with 0.2 μg of plasmids 
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encoding GFP-ARF1 WT or GFP-ARF1 Q71L, or 0.5 μg of the plasmid encoding GFP-GBF1 
A795E. Experiments were performed 16-17 h post transfection. 
Antibodies 
Rabbit anti-golgin-160 N-terminal head domain was previously described and validated 
(Chandran and Machamer, 2008). Rabbit anti-golgin-160 C-terminus was also previously 
described and validated (Hicks and Machamer, 2002). Mouse anti-GBF1, -GM130, -
GGA2, -GGA3, -p115, and -p230 were obtained from BD Transduction Laboratories (San 
Jose, CA, USA). Mouse anti- β-COP, -actin (A3853), -ERGIC-53, and -AP-1 (gamma 
adaptin) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Rabbit anti-GCC1 and -
GCC2 were obtained from Atlas Antibodies (Bromma, Sweden). Mouse anti-golgin-97 
was obtained from Molecular Probes/Thermo Fisher Scientific (Rockford, IL, USA). 
Rabbit anti-giantin was obtained from Covance/BioLegend (San Diego, CA, USA). Mouse 
anti-ARF1 was obtained from Cell Biolabs, Inc. (San Diego, CA, USA). Rabbit anti-BIG1 
and -BIG2 were previously described (Lowery et al., 2013). Alexa Fluor 568 anti-mouse 
IgG and Alexa Fluor 488 anti-rabbit IgG were from Life Technologies (Grand Island, NY, 
USA). Cy5-conjugated AffiniPure Donkey anti-rabbit IgG was obtained from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA, USA). IRDye 680RD goat anti-
mouse IgG and 680RD donkey anti-rabbit IgG were obtained from LI-COR, Inc. (Lincoln, 






For all temperature shifts, cells were placed in normal growth medium containing 20 
mM HEPES (Cellgro, Manassas, VA, USA) that had been pre-chilled to 20 or 16oC. Dishes 
were parafilmed closed and placed in water baths set to 20 or 16oC for 3 h (or the 
indicated time). For recovery at 37oC, after cells were first incubated at 16oC for 3 h, the 
medium was exchanged for media lacking HEPES that had been pre-warmed at 37oC and 
cells were returned to a 37oC incubator with 5% CO2.  
Indirect Immunofluorescence Microscopy and Quantification 
Cells were plated on 15 or 35 mm dishes with coverslips for 24 h before transfection 
with GBF1 or ARF1 constructs, or 48 h for analysis of endogenous proteins, before 
temperature shifts were performed. At the indicated times post temperature shift, cells 
were fixed with 3% paraformaldehyde in PBS for 10 min at room temperature. For most 
antibodies, cells were permeabilized for 10 min with 0.02% saponin (CalBiochem/Sigma) 
and 10 mM glycine (Sigma) in phosphate buffered saline (PBS; Sap/PBS/gly buffer). 
Coverslips were incubated 15 min in primary antibody diluted in Sap/PBS/gly buffer with 
1% bovine serum albumin (BSA). Cells were washed 2 times with Sap/PBS/gly buffer 
before being incubated in secondary antibody diluted as above. Cells were washed again 
before being incubated for 3 min in 0.1 μg/mL Hoechst 33258 diluted in PBS. Coverslips 
were then mounted in glycerol with 0.1 M N-propyl gallate.  
Several antibodies (BIG1, BIG2, β-COP) required permeabilization in 0.5% Triton X-100 in 
PBS/10 mM glycine for 3 min. For these antibodies, coverslips were washed in 
131 
 
PBS/glycine buffer without saponin, and antibodies were also diluted in PBS/glycine 
with 1% BSA.  
Coverslips were imaged on an Axioskop microscope (Zeiss, Thornwood, NY, USA) 
equipped for epifluorescence using an ORCA-03G charge-coupled device camera 
(Hamamatsu, Japan) using iVision software (BioVision Technologies, Exton, PA, USA). All 
images are shown inverted for better visualization of cytoplasmic localization. For 
quantification of golgin-160 localization, regions of interest (ROI) were created around 
the Golgi region using the GM130 image as well as around the whole cell, and the 
integrated pixel density of the golgin-160 signal in each ROI was determined using FIJI 
(National Institutes of Health, Bethesda, MD, USA). For each experiment, control images 
where fluorescent light was blocked from reaching the camera (no photon controls) 
were also taken to account for variations in camera light detection. Adjusted integrated 
pixel densities for each ROI were calculated by subtracting the pixel density measured in 
the control images from the corresponding experimental image pixel densities. To 
calculate the percent of golgin-160 at the Golgi, the adjusted integrated pixel density at 
the Golgi was divided by that of the whole cell. This percent was then normalized to 
37oC by dividing each individual percent by the average percent at 37oC. For 
endogenous protein quantification, 3 independent experiments were performed and 
between 180-300 cells were quantified per condition. For transfected cell experiments, 
4 independent experiments were performed and between 130-190 cells were quantified 
per condition. For all box and whiskers plots, the center bar represents the mean, the 
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box extends from the 25th to the 75th percentiles, and the whiskers extend to the 
minimum and maximum values.  
Golgin-160 expression levels 
HeLa cells were seeded on 35 mm dishes and allowed to grow for 48 h before being 
shifted to 20 or 16oC as described above. After 3 h, cells were washed with PBS twice 
and then lysed on ice for 10 min in lysis buffer (1% NP-40, 0.4% DOC, 50 mM Tris, pH 
8.0, 62.5 mM EDTA, pH 8.0) containing protease inhibitors. The lysate was separated by 
SDS-PAGE (10% acrylamide) and golgin-160 and actin were detected by immunoblotting 
after transfer to Immobilon-FL PVDF (EMD Millipore, Billerica, MA, USA), by near-
infrared fluorescent imaging on the Odyssey CLx Imaging System (LI-COR, Lincoln, NE, 
USA). The amount of protein in each lane was measured using Quantity One volume 
analysis tools (Bio-Rad, Hercules, CA, USA). The graph represents the mean value of 5 
independent replicates, and the error bars represent standard deviation. 
Active ARF1-GTP Pull Down 
The amount of active ARF1-GTP in HeLa cells at each temperature condition was 
determined using the ARF1 Activation Assay kit (Cell Biolabs, Inc., San Diego, CA, USA). 
In brief, three 6 cm dishes of HeLa cells were incubated at each condition, 37, 20, or 
16oC, for 3 h as described above. Three recovery dishes were incubated at 16oC for 3 h 
before being returned to 37oC for 0.5 h. The cells were then lysed on ice using the kit 
lysis buffer with protease inhibitors for 10 min. After clarification of the lysate, 10% 
input was removed and the remaining lysate was added to 40 μL of GGA3 protein 
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binding domain (PBD) agarose bead slurry. The lysates and beads were rotated for 1 h at 
4oC before the beads were washed 3 times in lysis buffer. The beads were resuspended 
in 40 μL SDS-PAGE loading sample buffer (0.1 M Tris, pH 6.8, 0.04% SDS, 30% glycerol, 
0.1% bromophenol blue) with 4% BME and boiled for 3 min at 95oC. The input and 50% 
of the pull down for each condition were then separated on a 4-12% NuPAGE Bis/Tris 
gel (Thermo Fisher Scientific), transferred to PVDF, and analyzed for ARF1 via Western 
blotting. Blots were imaged on the Odyssey CLx Imaging System and the amount of 
protein in each lane was measured using Image Studio (LI-COR, Lincoln, NE, USA). n=3 
for the recovery condition, and n=5 for all other conditions. The center line on the 
scatter plot represents the mean and the error bars represent the standard deviation. 
Statistical Analysis 
Graphs and statistical analyses were obtained using GraphPad Prism version 7.00 for 
Mac OS X (GraphPad Software, La Jolla, CA, USA). For all experiments, one-way ANOVA 
followed by Tukey’s multiple comparisons test were performed. For the microscopy 
data, outliers were identified using Prism’s Robust Regression and Outlier removal 
(ROUT) tool with Q set to 1%. Between 0-1 outliers (out of 130-300 measurements) per 




The objective of this thesis was to understand how the cis-Golgi localized 
protein, golgin-160, was affecting the post-Golgi trafficking of its cargo protein, β1AR. In 
the pursuit of that goal, we have characterized the binding interaction between these 
two proteins and have identified three basic residues on the third intercellular loop of 
β1AR that are critical for this interaction. We have also discovered that golgin-160 is 
temporarily displaced from Golgi membranes when a bolus of β1AR exits the cis-Golgi. 
While our analysis is complicated by the discovery that golgin-160 localization is 
artificially disrupted by a commonly used synchronization technique, new technologies 
are providing alternative strategies to modulate cargo trafficking. One such technique, 
the RUSH system, allowed us to examine the dynamics of β1AR trafficking in post-Golgi 
vesicles in the absence of golgin-160. These vesicles could move at similar speeds to 
those from cells containing golgin-160, but they had defects in maintaining processive 
movement. This suggests the intriguing possibility that golgin-160 may be altering 
interactions between β1AR containing vesicles and multiprotein scaffolding complexes 
that link vesicles to motor proteins. 
The N-terminal head domain of golgin-160 contains multiple localization signals 
and protein interaction domains. The same region, encompassing residues 140-257, is 
the site for ARF1-GTP binding and β1AR binding, and also contains a cryptic nuclear 
localization signal that can be revealed after secretory stress-induced cleavage by 
caspases (Hicks and Machamer, 2002; Hicks et al., 2006; Yadav et al., 2012). ARF1-GTP is 
required for Golgi membrane localization of golgin-160 (Yadav et al., 2012), therefore 
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our data showing that expression of β1AR induces loss of golgin-160 Golgi localization fit 
with a model in which golgin-160 changes from binding ARF1-GTP to β1AR. Golgin-160 
does not disperse until after β1AR has left the cis-Golgi, which suggests that the 
multipass transmembrane β1AR maintains its interaction with golgin-160 until it leaves 
that compartment. Determining what changes dictate golgin-160 binding to β1AR and 
release will be very informative for understanding the localization changes and 
mechanism of golgin-160 promoted trafficking. The RUSH system could be used in 
conjunction with proteomics assays to study the cleavage and post translational 
modification state of golgin-160 at distinct stages during β1AR trafficking, and the 
effects of any changes to golgin-160 on the binding between these two proteins could 
be analyzed. 
The RUSH system in conjunction with improvement in microscopes and image 
analysis packages will also improve our understanding of how golgin-160 is impacting 
vesicle dynamics. The lattice light sheet microscope can image the entire cell depth 
quickly, and improvements to heating chambers and CO2 delivery, as well as optimizing 
fluorophore tags for improved signal to noise ratios, would make it an attractive system 
to image vesicle movements from the Golgi to the plasma membrane. Biochemical work 
to identify the cargo adaptors and scaffold complexes associated with β1AR containing 
vesicles in the presence and absence of golgin-160 could also provide mechanistic 
insight to how golgin-160 is affecting vesicle trafficking. 
It is interesting to note that golgin-160 is only found in vertebrates, and only 
affects a small (that we are aware of) subset of the proteins that pass through the Golgi. 
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Has golgin-160 evolved to fulfill a purpose not required in non-vertebrates? The three 
known golgin-160-dependent cargo proteins are multipass transmembrane proteins 
that can have deleterious effects when their localization to the plasma membrane is 
altered, and therefore their localization needs to be tightly regulated. And yet golgin-
160 effects them in different ways – promoting 1AR and ROMK delivery to the plasma 
membrane, but preventing GLUT4 from traveling directly to the plasma membrane from 
the medial Golgi. Perhaps a unifying characteristic of these cargo proteins might be 
altered localization in response to cell stresses. Golgin-160 is cleaved early in response 
to secretory stress-induced apoptosis (Mancini et al., 2000). There may be a benefit to 
altering the localization of these particular proteins under stress conditions, for example 
by rapidly increasing glucose entry by having GLUT4 bypass GSVs, or increasing the 
amount of intracellular 1AR signaling. There may in fact be a connecting feature 
between these proteins that will only be revealed as improvements in protein trafficking 
assays allow us to identify more golgin-160-dependent cargo proteins.  
An increasing number of protein tag or modification based synchronization 
systems, like the RUSH system, are being developed. Our work demonstrating that the 
commonly used temperature block method of protein synchronization causes significant 
changes to the localization and function of Golgi proteins proves that these alternate 
systems are necessary to gain an accurate understanding of protein trafficking through 
the secretory system. Golgin-160 becomes cytoplasmic when these blocks are used, and 
therefore is likely not performing its Golgi-based function. While golgin-160 can recover 
to the Golgi after cells are returned to 37oC, it is not an immediate recovery. In contrast, 
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synchronized cargo immediately begins trafficking through the secretory pathway, and 
therefore golgin-160 may still be predominantly cytoplasmic when cargo proteins are 
passing through the cis-Golgi. It is therefore possible that there are additional proteins 
with golgin-160 facilitated trafficking that have remained undiscovered, as the assays 
used to test protein requirements for cargo trafficking may have essentially been 
performed in golgin-160 depleted cells. 
The changes in golgin-160 localization at reduced temperatures are due to 
preventing the activation of ARF1 through inhibition of GBF1, and another lab has 
reported that ARF3 is also mislocalized and likely inactive at cold temperatures. This 
could explain why numerous proteins at both the cis- and trans-Golgi also have altered 
localization in response to cold shifts. Why ARF-independent proteins are also affected 
by cold shifts is currently unknown, but could be through altering the function or activity 
of other GTPases that are critical to protein trafficking through the secretory system. 
Regardless of the precise mechanism, the data presented here indicate that results 
obtained using these methods need to be critically assessed and verified. Using 
alternate methods may lead to the discovery of more golgin-160 dependent cargo 












GBF1 and the GBF1-ARNO Chimera GARG can  





GBF1 (Golgi Brefeldin A Resistant Guanine Nucleotide Exchange Factor 1) is a 
large GEF that facilitates ADP-ribosylation factor 1 (ARF1) activation (Gillingham and 
Munro, 2007). Golgin-160 is an ARF1 effector, and depletion of GBF1 causes loss of 
golgin-160 Golgi localization (Yadav et al., 2012). The lab of Dr. Elizabeth Sztul at the 
University of Alabama at Birmingham generated a chimera of two ARF1 GEFs, the large 
GEF GBF1 and the pleckstrin homology (PH) domain containing ARF GEF ARNO (ARF 
nucleotide-binding site opener, also known as cytohesin-2) (Nawrotek et al., 2016). The 
chimera, called GBF1-ARNO-GBF1 or GARG, consists of the GBF1 A795E backbone (a 
mutation which confers brefeldin A, BFA, resistance) with the sec7 catalytic domain of 
ARNO. The purpose of these experiments was to characterize both the ability of GBF1 to 
support the localization and function of golgin-160, and examine how altering the sec7 
domain (with the ARNO mutant) affects this ability. 
BFA inhibits the large ARF GEFs, including GBF1, and treating cells with BFA also 
leads to loss of golgin-160 localization, as well as the general collapse of the Golgi into 
the ER (Lippincott-Schwartz et al., 1990; Yadav et al., 2012). We confirmed the loss of 
golgin-160 localization in the presence of BFA, as well as the loss of Golgi structure seen 
by the redistribution of giantin in BFA treated cells. We also demonstrated that the BFA 
resistant GBF1 mutant, GBF1 A795E, could prevent the mislocalization of both golgin-
160 and giantin, indicating that the Golgi structure and the activity of ARF1 were 
restored in GBF1 A795E transfected cells (Figure A-1A). Immunofluorescence 
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microscopy of golgin-160 and giantin demonstrated that cells expressing GARG also 
maintained intact Golgi structures in the presence of BFA (Figure A-1B).  
We next tested the ability of GBF1 to support not just the localization but also 
the function of golgin-160. Golgin-160 promotes the efficient trafficking of the beta-1 
adrenergic receptor (β1AR) to the plasma membrane. Using the retention using 
selective hooks (RUSH, described in Chapter 3) system, we demonstrated by 
immunofluorescence microscopy that β1AR trafficking to the plasma membrane was 
inhibited in the presence of BFA (Figure A-2A). This inhibition was relieved by co-
expression of the GBF1 A795E mutant (Figure A-2B). This observation was confirmed 
using a radiolabeled ligand binding assay. [3H]-CGP-12177 is a tritiated β1AR-specific cell 
impermeable ligand. HeLa cells expressing β1AR alone or β1AR and GBF1 A795E were 
pre-treated for 45 min with BFA before 10 uM biotin was added to release RUSH β1AR 
from the ER. An increase in the surface levels of β1AR over time was observed only in 
cells co-expressing GBF1 A795E (Figure A-2C). A smaller scale experiment showed that 
GARG could also promote β1AR trafficking to the plasma membrane in the presence of 
BFA (Figure A-2D). 
Finally, we had previously observed that expression of constitutively expressed 
β1AR leads to a decrease in Golgi localized golgin-160, and that this phenotype could 
not be prevented by expression of GBF1 (discussed in Chapter 3, Figure 3-1). GARG 
could not prevent this β1AR-induced loss of golgin-160 localization, either (Figure A3-A 
and B, β1AR alone and GBF1 transfected data from Figure 3-1 replicated here for 








Figure A-1: GBF1 A795E and GARG both maintain Golgi structure and golgin-160 
recruitment to Golgi membranes in BFA-treated cells. HeLa cells transiently transfected 
for 16 h with (A) GFP-GBF1 A795E or (B) GFP-GARG were either left untreated (-BFA) or 
treated with 0.5 mg/mL BFA for 45 min (+BFA) before the localization of the GFP 
constructs, endogenous and transfected GBF1, golgin-160, and giantin were assessed by 
immunofluorescence microscopy. GFP was used to identify transfected cells, and cells 
were labeled with mouse anti-GBF1, and rabbit anti-golgin-160 or -giantin, followed by 















Figure A-2: GBF1 A795E and GARG can promote the surface delivery of RUSH β1AR to 
the plasma membrane in the presence of BFA. (A-B) HeLa cells that were either 
expressing RUSH β1AR alone (A) or co-expressing RUSH β1AR with GBF1 A795E (B) were 
pretreated with BFA for 45 minutes before biotin was added for the indicated times to 
release β1AR from the ER. Surface staining was performed to visualize the effects of BFA 
and GBF1 A795E on the plasma membrane delivery of β1AR. The surface pool was 
detected using rabbit anti-mCherry followed by Alexa Fluor 488 anti-rabbit IgG, and was 
compared to total β1AR localization measured by mCherry fluorescence. Mouse anti-
GBF1 was used, followed by Cy5 anti-mouse IgG, to detect endogenous and transfected 
GBF1. (C) Cells were transfected and pretreated with BFA identically to (A-B) and the 
surface pool of β1AR was quantified using the availability of β1AR to bind the cell-
impermeable radiolabeled ligand [3H]CGP-12177. Radioactive counts per minute were 
normalized to β1AR expression levels. A representative experiment is shown. (D) The 
same protocol was used as in (C), but cells were transfected with RUSH β1AR alone or 























Figure A-3. GARG does not prevent the β1AR-induced loss of golgin-160 Golgi 
localization. Representative images of HeLa cells transfected with mCherry-β1AR alone, 
mCherry-β1AR and HA-GBF1, or mCherry-β1AR and HA-GARG for 18 h. Cells were 
labeled with rabbit anti-golgin-160 and mouse anti-GM130, followed by Cy5 anti-rabbit 
IgG and Alexa Fluor 488 anti-mouse IgG. mCherry fluorescence was used to identify 
transfected and co-transfected cells. Arrows indicate the Golgi regions of β1AR 
expressing cells. (C) Quantification of golgin-160 dispersal. The GM130 signal was used 
to outline the Golgi region in each cell, and the amount of golgin-160 fluorescent signal 
was calculated within the Golgi and divided by the total golgin-160 fluorescence in the 
cell to obtain the percent of golgin-160 at the Golgi. Each fluorescence intensity value 










Overall, these data show that both GBF1 and the sec7 chimera GARG can 
promote the localization and function of golgin-160. Experiments in BFA-treated cells 
demonstrated the sufficiency of GBF1 for this role. This is important as ARF1 also 
localizes to the trans-Golgi where it is activated by two other large GEFs, brefeldin A-
inhibited guanine nucleotide exchange proteins 1 and 2 (BIG1/2). Golgin-160 facilitates a 
late-Golgi trafficking step to promote β1AR surface delivery; therefore an attractive 
hypothesis is that golgin-160 can be recruited by ARF1 to both the cis- and trans-Golgi. 
While these experiments show that overall β1AR trafficking is restored by coexpression 
of GBF1 or GARG in the presence of BFA, further experiments will be needed to 
determine if this is the maximal surface delivery, or if BIG1/2-mediated recruitment of 




Materials and Methods 
HeLa Cell Culture 
HeLa cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; Life 
technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum 
(Atlanta Biologicals, Flowery Branch, GA, USA) and 0.1 mg/mL Normocin (InvivoGen, San 
Diego, CA, USA) at 37oC with 5% CO2.  
Expression Plasmids and Transfection 
HA-GBF1 A795E and HA-GARG were provided by Elizabeth Sztul (University of Alabama 
at Birmingham, Birmingham, AL, USA). They were subcloned into the eGFP C1 backbone 
(Clontech, Mountain View, CA, USA). Human FLAG- β1AR was provided by Randy Hall 
(Emory University, Atlanta, GA, USA). The mCherry β1AR and RUSH β1AR plasmids were 
constructed as described in Chapter 3. All plasmids were confirmed by sequencing. 
HeLa cells were plated in 35 mm dishes and transfected at ~70% confluency using X-
tremeGENE9 DNA transfection reagent (Roche, Indianapolis, IN, USA) according to 
manufacturer instructions. For immunofluorescence, 0.5 ug of each plasmid was used. 
For radiolabeled ligand binding, 1 ug of each construct was used. RUSH β1AR was 
transfected for 20 h before cells were manipulated as described below. All other 






Rabbit anti-golgin-160 N-terminal head domain was previously described (Chandran and 
Machamer, 2008). Mouse anti-GBF1 and -GM130 were obtained from BD Transduction 
Laboratories (San Jose, CA, USA). Mouse anti-mCherry was obtained from Sigma-Aldrich 
(St. Louis, MO, USA). Rabbit anti-giantin was obtained from Covance/BioLegend (San 
Diego, CA, USA). Rabbit anti-β1AR was obtained from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). -Alexa Fluor 568 anti-mouse IgG and Alexa Fluor 488 rabbit IgG were 
from Life Technologies (Grand Island, NY, USA). Cy5-conjugated AffiniPure donkey anti-
rabbit IgG and Cy5 conjugated donkey anti mouse IgG were obtained from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA, USA. IRDye 680RD donkey anti-
rabbit IgG were obtained from LI-COR, Inc. (Lincoln, NE, USA). 
Brefeldin A and Biotin Treatments 
BFA was obtained from Sigma and diluted in DMSO for a stock concentration of 5 
mg/mL. This was diluted to a 0.5 mg/mL working concentration in DMEM prior to being 
added to cells. Cells were pre-treated for 45 min before being processed for imaging or 
(for RUSH β1AR experiments) before biotin was added. Biotin (from Sigma) was diluted 
to 40 uM in serum free DMEM and was filter sterilized with a 0.22 um filter. Biotin was 
further diluted to 10 uM in DMEM supplemented with 10% FBS prior to being added to 






Cells were permeabilized for 10 min with 0.02% saponin (CalBiochem/Sigma) and 10 
mM glycine (Sigma) in phosphate buffered saline (PBS; Sap/PBS/gly buffer). Coverslips 
were incubated 15 min in primary antibody diluted in Sap/PBS/gly buffer with 1% bovine 
serum albumin (BSA). Cells were washed 2 times with Sap/PBS/gly buffer before being 
incubated in secondary antibody diluted as above. Cells were washed again before being 
incubated for 3 min in 0.1 μg/mL Hoechst 33258 diluted in PBS. Coverslips were then 
mounted in glycerol with 0.1 M N-propyl gallate. 
For surface staining, after BFA and biotin treatment for the indicated times, cells were 
washed with ice cold PBS before intact cells were incubated with primary antibody 
diluted in PBS on ice for 15 min. Cells were then permeabilized and labeled with internal 
and secondary antibodies as described above. 
Cells were imaged on an Axioskop microscope (Zeiss, Thornwood, NY, USA) equipped 
with epifluorescence using an ORCA-03G charge-coupled device camera (Hamamatsu, 
Japan) using iVision software (BioVision Technologies, Exton, PA, USA). For Figure A-3, 
the Golgi regions of interest (ROI) were created using the GM130 image. The integrated 
pixel density of the golgin-160 signal in each Golgi ROI as well as in the whole cell was 
determined using FIJI (National Institutes of Health, Bethesda, MD, USA). To calculate 
the percent of golgin-160 at the Golgi, the integrated pixel density at the Golgi was 
divided by that of the whole cell. This percent was then normalized to untransfected 
cells by dividing each individual percent by the average percent in untransfected cells.  
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Radiolabeled Surface Ligand Binding Assay 
Four 35 mm dishes were split for each condition, three for the radiolabeled surface 
ligand binding assay, one to lyse to control for β1AR expression level. For the ligand 
binding assay, cells were pretreated with BFA and incubated for the appropriate amount 
of time, as indicated. Cells were washed 3 times in ice cold PBS and cold KRH buffer (136 
mM NaCl, 4.7 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 20 mM HEPES pH 7.4, 2 mg/mL 
BSA) with 5 nM (-)-[3H]CGP-12177 (PerkinElmer, Boston, MA, USA). Dishes were rocked 
for 3 h at 4oC. Cells were then washed 3 times in ice cold PBS before cells were lysed in 
the dishes with detergent solution (1% NP-40, 0.4% deoxycholic acid, 50 mM Tris pH 8, 
62.5 mM EDTA pH 8 with protease inhibitors) for 10 min on ice. The lysate was then 
suspended in Bio-Safe II Biodegradable Scintillation Cocktail (Research Products 
International, Mt. Prospect, IL, USA) and counted on a LS 6500 Multi-Purpose 
Scintillation Counter (Beckman-Coulter, Brea, CA, USA). 
To normalize for β1AR expression level, the fourth dish was lysed on ice for 10 min in 
detergent solution. The protein was separated on a 10% polyacrylamide gel, and β1AR 
was detected by immunoblotting after transfer to Immobilon-FL PVDF (EMD Millipore, 
Billerica, MA, USA), by near-infrared fluorescent imaging on the Odyssey CLx Imaging 
System (LI-COR, Lincoln, NE, USA). Protein levels were calculated using Image Studio 
version 4.0 (LI-COR) and normalized to β1AR alone expression levels. The counts per 





Statistical analysis of golgin-160 localization during co-expression of GARG and β1AR 
was obtained using GraphPad Prism version 7.00 for Mac OS X (GraphPad Software, La 
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